Exact Mass: 676.3822

Exact Mass Matches: 676.3822

Found 298 metabolites which its exact mass value is equals to given mass value 676.3822, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Cucurbitacin I 2-glucoside

14-[(4E)-2,6-dihydroxy-6-methyl-3-oxohept-4-en-2-yl]-13-hydroxy-1,6,6,11,15-pentamethyl-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}tetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadeca-3,7-diene-5,17-dione

C36H52O12 (676.3459)


Cucurbitacin I 2-glucoside is a constituent of Citrullus lanatus Constituent of Citrullus lanatus

   

Gingerglycolipid A

2-Hydroxy-3-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}propyl (9Z,12Z,15Z)-octadeca-9,12,15-trienoic acid

C33H56O14 (676.367)


Gingerglycolipid A is found in ginger. Gingerglycolipid A is a constituent of Zingiber officinale (ginger). Constituent of Zingiber officinale (ginger). Gingerglycolipid A is found in herbs and spices and ginger.

   

(S)-Nerolidol 3-O-[a-L-Rhamnopyranosyl-(1->4)-a-L-rhamnopyranosyl-(1->2)-b-D-glucopyranoside]

2-[(6-{[4,5-dihydroxy-6-(hydroxymethyl)-2-{[(6E)-3,7,11-trimethyldodeca-1,6,10-trien-3-yl]oxy}oxan-3-yl]oxy}-4,5-dihydroxy-2-methyloxan-3-yl)oxy]-6-methyloxane-3,4,5-triol

C33H56O14 (676.367)


(S)-Nerolidol 3-O-[a-L-Rhamnopyranosyl-(1->4)-a-L-rhamnopyranosyl-(1->2)-b-D-glucopyranoside] is found in fruits. (S)-Nerolidol 3-O-[a-L-Rhamnopyranosyl-(1->4)-a-L-rhamnopyranosyl-(1->2)-b-D-glucopyranoside] is a constituent of Eriobotrya japonica (loquat). Constituent of Eriobotrya japonica (loquat). (S)-Nerolidol 3-O-[a-L-Rhamnopyranosyl-(1->4)-a-L-rhamnopyranosyl-(1->2)-b-D-glucopyranoside] is found in loquat and fruits.

   

(S)-Nerolidol 3-O-[a-L-rhamnopyranosyl-(1->4)-a-L-rhamnopyranosyl-(1->6)-b-D-glucopyranoside]

2-({4,5-dihydroxy-2-methyl-6-[(3,4,5-trihydroxy-6-{[(6E)-3,7,11-trimethyldodeca-1,6,10-trien-3-yl]oxy}oxan-2-yl)methoxy]oxan-3-yl}oxy)-6-methyloxane-3,4,5-triol

C33H56O14 (676.367)


(S)-Nerolidol 3-O-[a-L-rhamnopyranosyl-(1->4)-a-L-rhamnopyranosyl-(1->6)-b-D-glucopyranoside] is found in fruits. (S)-Nerolidol 3-O-[a-L-rhamnopyranosyl-(1->4)-a-L-rhamnopyranosyl-(1->6)-b-D-glucopyranoside] is a constituent of Eriobotrya japonica (loquat). Constituent of Eriobotrya japonica (loquat). (S)-Nerolidol 3-O-[a-L-rhamnopyranosyl-(1->4)-a-L-rhamnopyranosyl-(1->6)-b-D-glucopyranoside] is found in loquat and fruits.

   

Actein

[2-Hydroxy-1,4,6,12,17,17-hexamethyl-18-(3,4,5-trihydroxyoxan-2-yl)oxyspiro[3,6-dioxabicyclo[3.1.0]hexane-4,8-9-oxahexacyclo[11.9.0.01,21.04,12.05,10.016,21]docosane]-3-yl] acetate

C37H56O11 (676.3822)


   

PA(13:0/5-iso PGF2VI)

[(2R)-2-{[(3Z)-5-[(1S,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3R)-3-hydroxyoct-1-en-1-yl]cyclopentyl]pent-3-enoyl]oxy}-3-(tridecanoyloxy)propoxy]phosphonic acid

C34H61O11P (676.3951)


PA(13:0/5-iso PGF2VI) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(13:0/5-iso PGF2VI), in particular, consists of one chain of one tridecanoyl at the C-1 position and one chain of 5-iso Prostaglandin F2alpha-VI at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

   

PA(5-iso PGF2VI/13:0)

[(2R)-3-{[(3Z)-5-[(1S,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3R)-3-hydroxyoct-1-en-1-yl]cyclopentyl]pent-3-enoyl]oxy}-2-(tridecanoyloxy)propoxy]phosphonic acid

C34H61O11P (676.3951)


PA(5-iso PGF2VI/13:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(5-iso PGF2VI/13:0), in particular, consists of one chain of one 5-iso Prostaglandin F2alpha-VI at the C-1 position and one chain of tridecanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

   

PA(14:1(9Z)/18:1(12Z)-2OH(9,10))

[(2R)-2-{[(9S,10S,12Z)-9,10-dihydroxyoctadec-12-enoyl]oxy}-3-[(9Z)-tetradec-9-enoyloxy]propoxy]phosphonic acid

C35H65O10P (676.4315)


PA(14:1(9Z)/18:1(12Z)-2OH(9,10)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(14:1(9Z)/18:1(12Z)-2OH(9,10)), in particular, consists of one chain of one 9Z-tetradecenoyl at the C-1 position and one chain of 9,10-hydroxy-octadecenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

   

PA(18:1(12Z)-2OH(9,10)/14:1(9Z))

PA(18:1(12Z)-2OH(9,10)/14:1(9Z))

C35H65O10P (676.4315)


PA(18:1(12Z)-2OH(9,10)/14:1(9Z)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(18:1(12Z)-2OH(9,10)/14:1(9Z)), in particular, consists of one chain of one 9,10-hydroxy-octadecenoyl at the C-1 position and one chain of 9Z-tetradecenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

   

PA(a-13:0/5-iso PGF2VI)

[(2R)-2-{[(3Z)-5-[(1S,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3R)-3-hydroxyoct-1-en-1-yl]cyclopentyl]pent-3-enoyl]oxy}-3-[(10-methyldodecanoyl)oxy]propoxy]phosphonic acid

C34H61O11P (676.3951)


PA(a-13:0/5-iso PGF2VI) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(a-13:0/5-iso PGF2VI), in particular, consists of one chain of one 10-methyldodecanoyl at the C-1 position and one chain of 5-iso Prostaglandin F2alpha-VI at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

   

PA(5-iso PGF2VI/a-13:0)

[(2R)-3-{[(3Z)-5-[(1S,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3R)-3-hydroxyoct-1-en-1-yl]cyclopentyl]pent-3-enoyl]oxy}-2-[(10-methyldodecanoyl)oxy]propoxy]phosphonic acid

C34H61O11P (676.3951)


PA(5-iso PGF2VI/a-13:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(5-iso PGF2VI/a-13:0), in particular, consists of one chain of one 5-iso Prostaglandin F2alpha-VI at the C-1 position and one chain of 10-methyldodecanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

   

PA(i-13:0/5-iso PGF2VI)

[(2R)-2-{[(3Z)-5-[(1S,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3R)-3-hydroxyoct-1-en-1-yl]cyclopentyl]pent-3-enoyl]oxy}-3-[(11-methyldodecanoyl)oxy]propoxy]phosphonic acid

C34H61O11P (676.3951)


PA(i-13:0/5-iso PGF2VI) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(i-13:0/5-iso PGF2VI), in particular, consists of one chain of one 11-methyldodecanoyl at the C-1 position and one chain of 5-iso Prostaglandin F2alpha-VI at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

   

PA(5-iso PGF2VI/i-13:0)

[(2R)-3-{[(3Z)-5-[(1S,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3R)-3-hydroxyoct-1-en-1-yl]cyclopentyl]pent-3-enoyl]oxy}-2-[(11-methyldodecanoyl)oxy]propoxy]phosphonic acid

C34H61O11P (676.3951)


PA(5-iso PGF2VI/i-13:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(5-iso PGF2VI/i-13:0), in particular, consists of one chain of one 5-iso Prostaglandin F2alpha-VI at the C-1 position and one chain of 11-methyldodecanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

   
   

Acutissimatriterpene E

Acutissimatriterpene E

C40H52O9 (676.3611)


   

Cimiracemoside G

Cimiracemoside G

C37H56O11 (676.3822)


   
   
   

Rubianoside I

Rubianoside I

C38H60O10 (676.4186)


   

Actaeaepoxide 3-O-beta-D-xylopyranoside

Actaeaepoxide 3-O-beta-D-xylopyranoside

C37H56O11 (676.3822)


   
   

Hyalodendroside B

Hyalodendroside B

C38H60O10 (676.4186)


   

Enteridinine A

Enteridinine A

C34H60O13 (676.4034)


   
   

[(2R,3R,4S,5S,6R)-3-acetyloxy-2-(acetyloxymethyl)-5-hexanoyloxy-6-[(2S,3R)-2,3,4-trihydroxybutoxy]oxan-4-yl] tetradecanoate

[(2R,3R,4S,5S,6R)-3-acetyloxy-2-(acetyloxymethyl)-5-hexanoyloxy-6-[(2S,3R)-2,3,4-trihydroxybutoxy]oxan-4-yl] tetradecanoate

C34H60O13 (676.4034)


   

Hederagenin base + O-AcetylHex

Hederagenin base + O-AcetylHex

C38H60O10 (676.4186)


Annotation level-3

   

3R/S-hydroxy-N4-demethylervahanine B

3R/S-hydroxy-N4-demethylervahanine B

C41H48N4O5 (676.3625)


   

(18R)-18-hydroxydihydroalloprotolichesterinic acid 18-O-beta-D-glucopyranosyl-(1-2)-O-beta-D-glucopyranoside-(21,2-lactone)|gobienine A

(18R)-18-hydroxydihydroalloprotolichesterinic acid 18-O-beta-D-glucopyranosyl-(1-2)-O-beta-D-glucopyranoside-(21,2-lactone)|gobienine A

C33H56O14 (676.367)


   

??,??-Digalactosyl-??-linolenic-glyceride

??,??-Digalactosyl-??-linolenic-glyceride

C33H56O14 (676.367)


   

Actein

[(1S,1R,2S,3R,4R,4R,5R,5R,6R,10S,12S,13S,16R,18S,21R)-2-hydroxy-1,4,6,12,17,17-hexamethyl-18-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxyspiro[3,6-dioxabicyclo[3.1.0]hexane-4,8-9-oxahexacyclo[11.9.0.01,21.04,12.05,10.016,21]docosane]-3-yl] acetate

C37H56O11 (676.3822)


Actein is a triterpenoid. It has a role as a metabolite. Actein is a natural product found in Actaea elata, Actaea cimicifuga, and other organisms with data available. See also: Black Cohosh (part of). A natural product found in Actaea racemosa.

   

tabernaemontavine

tabernaemontavine

C42H52N4O4 (676.3988)


   

4a-[2-(5-ethyl-3,6-dihydro-2H-pyridin-1-yl)-ethyl]-4-{3-[2-(5-ethyl-3,6-dihydro-2H-pyridin-1-yl)-ethyl]-indol-2-yl}-3,4,4a,9-tetrahydro-2H-carbazole-1,4-dicarboxylic acid dimethyl ester|Presecamin|Presecamine

4a-[2-(5-ethyl-3,6-dihydro-2H-pyridin-1-yl)-ethyl]-4-{3-[2-(5-ethyl-3,6-dihydro-2H-pyridin-1-yl)-ethyl]-indol-2-yl}-3,4,4a,9-tetrahydro-2H-carbazole-1,4-dicarboxylic acid dimethyl ester|Presecamin|Presecamine

C42H52N4O4 (676.3988)


   

1??,3??-Hydroxyimberbic acid-23-O-??-L-4-acetylrhamnopyranoside

1??,3??-Hydroxyimberbic acid-23-O-??-L-4-acetylrhamnopyranoside

C38H60O10 (676.4186)


   

cycloorbicoside D

cycloorbicoside D

C38H60O10 (676.4186)


   

Thapsivillosin D

Thapsivillosin D

C36H52O12 (676.3459)


   
   

3-O-(Di-L-rhamnoside)- 3,14-Dihydroxybufa-4,20,22-trienolide

3-O-(Di-L-rhamnoside)- 3,14-Dihydroxybufa-4,20,22-trienolide

C36H52O12 (676.3459)


   
   

1-Ac,23-O-rhamnopyranoside-(1alpha,3beta)-1,3,23-Trihydroxy-12-oleanen-29-oic acid

1-Ac,23-O-rhamnopyranoside-(1alpha,3beta)-1,3,23-Trihydroxy-12-oleanen-29-oic acid

C38H60O10 (676.4186)


   

(23R,24R)-16beta,23;16alpha,24-diepoxy-12beta-acetoxy-cycloart-7-en-3beta,15alpha,25-triol 3-O-beta-D-xylopyranoside

(23R,24R)-16beta,23;16alpha,24-diepoxy-12beta-acetoxy-cycloart-7-en-3beta,15alpha,25-triol 3-O-beta-D-xylopyranoside

C37H56O11 (676.3822)


   

1-O-[2,3,4-tri-O-acetyl-alpha-L-rhamnopyranosyl-(1->2)-beta-D-glucopyranosyl]hexadecanol|cupanioside

1-O-[2,3,4-tri-O-acetyl-alpha-L-rhamnopyranosyl-(1->2)-beta-D-glucopyranosyl]hexadecanol|cupanioside

C34H60O13 (676.4034)


   

protoconstipatic acid (18S)-18-O-alpha-L-rhamnopyranosyl-(1-4)-beta-D-glucopyranoside

protoconstipatic acid (18S)-18-O-alpha-L-rhamnopyranosyl-(1-4)-beta-D-glucopyranoside

C33H56O14 (676.367)


   

3beta-O-(4-deoxy-beta-D-hex-4-enopyranosyluronic acid), 2beta,16alpha-dihydroxy-olean-12-en-23,18-dioic acid

3beta-O-(4-deoxy-beta-D-hex-4-enopyranosyluronic acid), 2beta,16alpha-dihydroxy-olean-12-en-23,18-dioic acid

C36H52O12 (676.3459)


   
   
   

3beta-O-(beta-D-glucuronopyranosyl)-olean-12-ene-28,29-dioic acid 29-methyl ester|coryternic acid 3-O-beta-D-glucuronopyranoside

3beta-O-(beta-D-glucuronopyranosyl)-olean-12-ene-28,29-dioic acid 29-methyl ester|coryternic acid 3-O-beta-D-glucuronopyranoside

C37H56O11 (676.3822)


   

murolic acid (18R)-18-O-alpha-L-rhamnopyranosyl-(1-6)-beta-D-glucopyranoside

murolic acid (18R)-18-O-alpha-L-rhamnopyranosyl-(1-6)-beta-D-glucopyranoside

C33H56O14 (676.367)


   

27-Deoxyactein

27-Deoxyactein

C37H56O11 (676.3822)


   

hederagenin-3-O-beta-D-glucuronopyranoside 6-O-methyl ester

hederagenin-3-O-beta-D-glucuronopyranoside 6-O-methyl ester

C38H60O10 (676.4186)


   

3beta,23-dihydroxy-urs-12-en-28-oic acid 3-O-beta-D-glucuronopyranoside 6-O-methyl ester

3beta,23-dihydroxy-urs-12-en-28-oic acid 3-O-beta-D-glucuronopyranoside 6-O-methyl ester

C38H60O10 (676.4186)


   

Hebelomic aicd E

Hebelomic aicd E

C38H60O10 (676.4186)


   

(20S*,22R*,23S*,24R*)-16beta:23:22:25-diepoxy-3beta,24-dihydroxy-23-methoxy-9,19-cyclolanostane-3-O-beta-D-(4-acetyl)xylopyranoside|soulieoside D

(20S*,22R*,23S*,24R*)-16beta:23:22:25-diepoxy-3beta,24-dihydroxy-23-methoxy-9,19-cyclolanostane-3-O-beta-D-(4-acetyl)xylopyranoside|soulieoside D

C38H60O10 (676.4186)


   

Delta16-adynerigenin beta-neribioside

Delta16-adynerigenin beta-neribioside

C36H52O12 (676.3459)


   

3R/S-hydroxy-N4-demethylervahanine A

3R/S-hydroxy-N4-demethylervahanine A

C41H48N4O5 (676.3625)


   

Tyr Arg Leu Ile Val

Tyr Arg Leu Ile Val

C33H56N8O7 (676.4272)


   

DGMG 18:3

[(2S)-2-Hydroxy-3-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxypropyl] (9Z,12Z,15Z)-octadeca-9,12,15-trienoate

C33H56O14 (676.367)


Gingerglycolipid A is a galactosylglycerol derivative. Gingerglycolipid A is a natural product found in Guapira graciliflora, Sonchus mauritanicus, and other organisms with data available. Annotation level-3

   

[(2R,3R,4S,5S,6R)-3-acetyloxy-2-(acetyloxymethyl)-5-hexanoyloxy-6-[(2S,3R)-2,3,4-trihydroxybutoxy]oxan-4-yl] tetradecanoate

NCGC00381100-01![(2R,3R,4S,5S,6R)-3-acetyloxy-2-(acetyloxymethyl)-5-hexanoyloxy-6-[(2S,3R)-2,3,4-trihydroxybutoxy]oxan-4-yl] tetradecanoate

C34H60O13 (676.4034)


   

C36H52O12_(4R,9beta,16alpha,23E)-16,20,25-Trihydroxy-9,10,14-trimethyl-1,11,22-trioxo-4,9-cyclo-9,10-secocholesta-2,5,23-trien-2-yl beta-D-glucopyranoside

NCGC00179885-03_C36H52O12_(4R,9beta,16alpha,23E)-16,20,25-Trihydroxy-9,10,14-trimethyl-1,11,22-trioxo-4,9-cyclo-9,10-secocholesta-2,5,23-trien-2-yl beta-D-glucopyranoside

C36H52O12 (676.3459)


   

6,8-dihydroxy-2,2,4,4-tetramethyl-7-(3-methylbutanoyl)-9-(2-methylpropyl)-9H-xanthene-1,3-dione

6,8-dihydroxy-2,2,4,4-tetramethyl-7-(3-methylbutanoyl)-9-(2-methylpropyl)-9H-xanthene-1,3-dione

C36H52O12 (676.3459)


   

[(2R,3R,4S,5S,6R)-3-acetyloxy-2-(acetyloxymethyl)-5-hexanoyloxy-6-[(2S,3R)-2,3,4-trihydroxybutoxy]oxan-4-yl] tetradecanoate_major

[(2R,3R,4S,5S,6R)-3-acetyloxy-2-(acetyloxymethyl)-5-hexanoyloxy-6-[(2S,3R)-2,3,4-trihydroxybutoxy]oxan-4-yl] tetradecanoate_major

C34H60O13 (676.4034)


   

[(2R,3R,4S,5S,6R)-3-acetyloxy-2-(acetyloxymethyl)-5-hexanoyloxy-6-[(2S,3R)-2,3,4-trihydroxybutoxy]oxan-4-yl] tetradecanoate_87.6\\%

[(2R,3R,4S,5S,6R)-3-acetyloxy-2-(acetyloxymethyl)-5-hexanoyloxy-6-[(2S,3R)-2,3,4-trihydroxybutoxy]oxan-4-yl] tetradecanoate_87.6\\%

C34H60O13 (676.4034)


   

6,8-dihydroxy-2,2,4,4-tetramethyl-7-(3-methylbutanoyl)-9-(2-methylpropyl)-9H-xanthene-1,3-dione_minor

6,8-dihydroxy-2,2,4,4-tetramethyl-7-(3-methylbutanoyl)-9-(2-methylpropyl)-9H-xanthene-1,3-dione_minor

C36H52O12 (676.3459)


   

6,8-dihydroxy-2,2,4,4-tetramethyl-7-(3-methylbutanoyl)-9-(2-methylpropyl)-9H-xanthene-1,3-dione_major

6,8-dihydroxy-2,2,4,4-tetramethyl-7-(3-methylbutanoyl)-9-(2-methylpropyl)-9H-xanthene-1,3-dione_major

C36H52O12 (676.3459)


   

[(2R,3R,4S,5S,6R)-3-acetyloxy-2-(acetyloxymethyl)-5-hexanoyloxy-6-[(2S,3R)-2,3,4-trihydroxybutoxy]oxan-4-yl] tetradecanoate_minor

[(2R,3R,4S,5S,6R)-3-acetyloxy-2-(acetyloxymethyl)-5-hexanoyloxy-6-[(2S,3R)-2,3,4-trihydroxybutoxy]oxan-4-yl] tetradecanoate_minor

C34H60O13 (676.4034)


   

6,8-dihydroxy-2,2,4,4-tetramethyl-7-(3-methylbutanoyl)-9-(2-methylpropyl)-9H-xanthene-1,3-dione_53.1\\%

6,8-dihydroxy-2,2,4,4-tetramethyl-7-(3-methylbutanoyl)-9-(2-methylpropyl)-9H-xanthene-1,3-dione_53.1\\%

C36H52O12 (676.3459)


   

[(2R,3R,4S,5S,6R)-3-acetyloxy-2-(acetyloxymethyl)-5-hexanoyloxy-6-[(2S,3R)-2,3,4-trihydroxybutoxy]oxan-4-yl] tetradecanoate_85.2\\%

[(2R,3R,4S,5S,6R)-3-acetyloxy-2-(acetyloxymethyl)-5-hexanoyloxy-6-[(2S,3R)-2,3,4-trihydroxybutoxy]oxan-4-yl] tetradecanoate_85.2\\%

C34H60O13 (676.4034)


   

[(2R,3R,4S,5S,6R)-3-acetyloxy-2-(acetyloxymethyl)-5-hexanoyloxy-6-[(2S,3R)-2,3,4-trihydroxybutoxy]oxan-4-yl] tetradecanoate_89.9\\%

[(2R,3R,4S,5S,6R)-3-acetyloxy-2-(acetyloxymethyl)-5-hexanoyloxy-6-[(2S,3R)-2,3,4-trihydroxybutoxy]oxan-4-yl] tetradecanoate_89.9\\%

C34H60O13 (676.4034)


   

Prostaglandin D2-biotin

9α,15S-dihydroxy-11-oxo-prosta-5Z,13E-dien-1-oyl-N-biotinoyl-1,5-diaminopentane

C36H60N4O6S (676.4233)


   

PG(12:0/17:2(9Z,12Z))

1-dodecanoyl-2-(9Z,12Z-heptadecadienoyl)-glycero-3-phospho-(1-sn-glycerol)

C35H65O10P (676.4315)


   

PG(14:1(9Z)/15:1(9Z))

1-(9Z-tetradecenoyl)-2-(9Z-pentadecenoyl)-glycero-3-phospho-(1-sn-glycerol)

C35H65O10P (676.4315)


   

PG(15:1(9Z)/14:1(9Z))

1-(9Z-pentadecenoyl)-2-(9Z-tetradecenoyl)-glycero-3-phospho-(1-sn-glycerol)

C35H65O10P (676.4315)


   

PG(17:2(9Z,12Z)/12:0)

1-(9Z,12Z-heptadecadienoyl)-2-dodecanoyl-glycero-3-phospho-(1-sn-glycerol)

C35H65O10P (676.4315)


   

Cucurbitacin I 2-glucoside

14-[(4E)-2,6-dihydroxy-6-methyl-3-oxohept-4-en-2-yl]-13-hydroxy-1,6,6,11,15-pentamethyl-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-3,7-diene-5,17-dione

C36H52O12 (676.3459)


   

(S)-Nerolidol 3-O-[a-L-Rhamnopyranosyl-(1->4)-a-L-rhamnopyranosyl-(1->2)-b-D-glucopyranoside]

2-[(6-{[4,5-dihydroxy-6-(hydroxymethyl)-2-{[(6E)-3,7,11-trimethyldodeca-1,6,10-trien-3-yl]oxy}oxan-3-yl]oxy}-4,5-dihydroxy-2-methyloxan-3-yl)oxy]-6-methyloxane-3,4,5-triol

C33H56O14 (676.367)


   

(S)-Nerolidol 3-O-[a-L-rhamnopyranosyl-(1->4)-a-L-rhamnopyranosyl-(1->6)-b-D-glucopyranoside]

2-[({3,4-dihydroxy-6-methyl-5-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]oxan-2-yl}oxy)methyl]-6-{[(6E)-3,7,11-trimethyldodeca-1,6,10-trien-3-yl]oxy}oxane-3,4,5-triol

C33H56O14 (676.367)


   

Gingerglycolipid A

2-hydroxy-3-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}propyl (9Z,12Z,15Z)-octadeca-9,12,15-trienoate

C33H56O14 (676.367)


   

(2S,3R)-2,3,4-Trihydroxybutyl 4,6-di-O-acetyl-2-O-hexanoyl-3-O-tetradecanoyl-?-D-mannopyranoside

(2S,3R)-2,3,4-Trihydroxybutyl 4,6-di-O-acetyl-2-O-hexanoyl-3-O-tetradecanoyl-?-D-mannopyranoside

C34H60O13 (676.4034)


   

Granadaene

(2S)-5-amino-2-(27R-O-alpha-L-rhamnopyranosyl-2E,4E,6E,8E,10E,12E,14E,16E,18E,20E,22E,24E-octacosadodecaenoyl)pentanoic acid

C39H52N2O8 (676.3723)


   

PG 29:2

1-(9Z-pentadecenoyl)-2-(9Z-tetradecenoyl)-glycero-3-phospho-(1-sn-glycerol)

C35H65O10P (676.4315)


   

Asteriidoside L

3beta-(beta-D-xylopyranosyloxy)-6beta,8beta,15alpha-trihydroxy-campest-22E-en-28-yl sulfate

C33H56O12S (676.3492)


   

Evasterioside A

(20R,22E,24R,25S)-3-O-(beta-D-xylopyranosyl)-24-methyl-5alpha-cholest-22-ene-3beta,6beta,8,15alpha,26-pentol 26-sulfate

C33H56O12S (676.3492)


   

Bastaxanthin B2

(3R,5S)-19-hydroxy-3,6-dioxo-7,8-didehydro-beta,kappa-caroten-3-yl sulphate

C40H52O7S (676.3434)


   

cadmium dioleate

cadmium dioleate

C36H66CdO4 (676.3994)


   

2,2-Bisnalmefene

2,2-Bisnalmefene

C42H48N2O6 (676.3512)


   

Rapacuronium Bromide

Rapacuronium Bromide

C37H61BrN2O4 (676.3814)


D018373 - Peripheral Nervous System Agents > D009465 - Neuromuscular Agents > D009466 - Neuromuscular Blocking Agents C78281 - Agent Affecting Musculoskeletal System > C29696 - Muscle Relaxant Rapacuronium bromide (Org 9487), a non-depolarizing neuromuscular blocker, is an allosteric modulator of muscarinic acetylcholine receptor (mAChR)[1].

   

Cimiracemoside A

Cimiracemoside A

C37H56O11 (676.3822)


   

(16alpha,20S,22S,23S)-16,23:22,25-diepoxy-2,22,23-trihydroxycucurbita-1,5-diene-3,11-dione 2-O-beta-D-glucopyranoside

(16alpha,20S,22S,23S)-16,23:22,25-diepoxy-2,22,23-trihydroxycucurbita-1,5-diene-3,11-dione 2-O-beta-D-glucopyranoside

C36H52O12 (676.3459)


A triterpenoid saponin of the class of cucurbitane glycosides isolated from the roots of Machilus yaoshansis.

   

PA(13:0/5-iso PGF2VI)

PA(13:0/5-iso PGF2VI)

C34H61O11P (676.3951)


   

PA(5-iso PGF2VI/13:0)

PA(5-iso PGF2VI/13:0)

C34H61O11P (676.3951)


   

PA(a-13:0/5-iso PGF2VI)

PA(a-13:0/5-iso PGF2VI)

C34H61O11P (676.3951)


   

PA(5-iso PGF2VI/a-13:0)

PA(5-iso PGF2VI/a-13:0)

C34H61O11P (676.3951)


   

PA(i-13:0/5-iso PGF2VI)

PA(i-13:0/5-iso PGF2VI)

C34H61O11P (676.3951)


   

PA(5-iso PGF2VI/i-13:0)

PA(5-iso PGF2VI/i-13:0)

C34H61O11P (676.3951)


   

PA(14:1(9Z)/18:1(12Z)-2OH(9,10))

PA(14:1(9Z)/18:1(12Z)-2OH(9,10))

C35H65O10P (676.4315)


   

PA(18:1(12Z)-2OH(9,10)/14:1(9Z))

PA(18:1(12Z)-2OH(9,10)/14:1(9Z))

C35H65O10P (676.4315)


   

Cucurbitacin I 2-O-beta-D-glucopyranoside

Cucurbitacin I 2-O-beta-D-glucopyranoside

C36H52O12 (676.3459)


A triterpenoid saponin that is cucurbitacin I attached to a beta-D-glucopyranosyl residue at position 2 via a glycosidic linkage. It has been isolated from Machilus yaoshansis.

   

(16alpha,20R,24S)-16,24-epoxy-2,20,25-trihydroxycucurbita-1,5-diene-3,11,22-trione 2-O-beta-D-glucopyranoside

(16alpha,20R,24S)-16,24-epoxy-2,20,25-trihydroxycucurbita-1,5-diene-3,11,22-trione 2-O-beta-D-glucopyranoside

C36H52O12 (676.3459)


A natural product found in Machilus yaoshansis.

   

[(E,2S,5R)-2-propan-2-yl-5-[(3S,5S,6R,8S,9R,10S,13R,14S,15S,17R)-6,8,15-trihydroxy-10,13-dimethyl-3-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxy-1,2,3,4,5,6,7,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]hex-3-enyl] hydrogen sulfate

[(E,2S,5R)-2-propan-2-yl-5-[(3S,5S,6R,8S,9R,10S,13R,14S,15S,17R)-6,8,15-trihydroxy-10,13-dimethyl-3-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxy-1,2,3,4,5,6,7,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]hex-3-enyl] hydrogen sulfate

C33H56O12S (676.3492)


   

(5R)-3-O-[(2E)-3-carboxyprop-2-enoyl]-2,4-dideoxy-1-C-{(2S,3R,4S)-3-hydroxy-4-[(2R,3S,4R,6R,9S,10S,11R,12R,14R)-10-hydroxy-3-methoxy-7,9,11,13,15-pentamethyl-16-oxooxacyclohexadeca-4,6,12,14-tetraen-2-yl]pentan-2-yl}-4,5-dimethyl-beta-L-erythro-pentopyranose

(5R)-3-O-[(2E)-3-carboxyprop-2-enoyl]-2,4-dideoxy-1-C-{(2S,3R,4S)-3-hydroxy-4-[(2R,3S,4R,6R,9S,10S,11R,12R,14R)-10-hydroxy-3-methoxy-7,9,11,13,15-pentamethyl-16-oxooxacyclohexadeca-4,6,12,14-tetraen-2-yl]pentan-2-yl}-4,5-dimethyl-beta-L-erythro-pentopyranose

C37H56O11 (676.3822)


   

[(2S)-2-hydroxy-3-[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-[[(2S,3S,4R,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxypropyl] (9Z,12Z,15Z)-octadeca-9,12,15-trienoate

[(2S)-2-hydroxy-3-[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-[[(2S,3S,4R,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxypropyl] (9Z,12Z,15Z)-octadeca-9,12,15-trienoate

C33H56O14 (676.367)


   

N-[5-[3-[3-(ethylamino)-6-ethylimino-2,7-dimethylxanthen-9-yl]propanoylamino]pentyl]-5-(2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl)pentanamide

N-[5-[3-[3-(ethylamino)-6-ethylimino-2,7-dimethylxanthen-9-yl]propanoylamino]pentyl]-5-(2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl)pentanamide

C37H52N6O4S (676.3771)


   

[(E,2S,3R,6R)-2,3-dimethyl-6-[(3S,5S,6R,8S,9R,10S,13R,14S,15S,17R)-6,8,15-trihydroxy-10,13-dimethyl-3-[(2S,3S,5R)-3,4,5-trihydroxyoxan-2-yl]oxy-1,2,3,4,5,6,7,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]hept-4-enyl] hydrogen sulfate

[(E,2S,3R,6R)-2,3-dimethyl-6-[(3S,5S,6R,8S,9R,10S,13R,14S,15S,17R)-6,8,15-trihydroxy-10,13-dimethyl-3-[(2S,3S,5R)-3,4,5-trihydroxyoxan-2-yl]oxy-1,2,3,4,5,6,7,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]hept-4-enyl] hydrogen sulfate

C33H56O12S (676.3492)


   

[2-hydroxy-3-[3,4,5-trihydroxy-6-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxypropyl] (9E,12E,15E)-octadeca-9,12,15-trienoate

[2-hydroxy-3-[3,4,5-trihydroxy-6-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxypropyl] (9E,12E,15E)-octadeca-9,12,15-trienoate

C33H56O14 (676.367)


   

[2-hydroxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropyl] (12Z,15Z,18Z,21Z)-tetracosa-12,15,18,21-tetraenoate

[2-hydroxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropyl] (12Z,15Z,18Z,21Z)-tetracosa-12,15,18,21-tetraenoate

C33H57O12P (676.3587)


   

Smgdg O-20:4_4:0

Smgdg O-20:4_4:0

C33H56O12S (676.3492)


   

Smgdg O-16:4_8:0

Smgdg O-16:4_8:0

C33H56O12S (676.3492)


   

Smgdg O-8:0_16:4

Smgdg O-8:0_16:4

C33H56O12S (676.3492)


   

Smgdg O-18:4_6:0

Smgdg O-18:4_6:0

C33H56O12S (676.3492)


   

Smgdg O-22:4_2:0

Smgdg O-22:4_2:0

C33H56O12S (676.3492)


   

Dgdg O-16:3_2:0

Dgdg O-16:3_2:0

C33H56O14 (676.367)


   

PMeOH 16:3_18:4

PMeOH 16:3_18:4

C38H61O8P (676.4104)


   

PMeOH 18:3_16:4

PMeOH 18:3_16:4

C38H61O8P (676.4104)


   

PMeOH 16:2_18:5

PMeOH 16:2_18:5

C38H61O8P (676.4104)


   

[1-heptanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate

[1-heptanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate

C38H60O10 (676.4186)


   

[1-[(2-heptanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (13Z,16Z)-docosa-13,16-dienoate

[1-[(2-heptanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (13Z,16Z)-docosa-13,16-dienoate

C35H65O10P (676.4315)


   

[1-hydroxy-3-[hydroxy-(3-hydroxy-2-propanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (15Z,18Z)-hexacosa-15,18-dienoate

[1-hydroxy-3-[hydroxy-(3-hydroxy-2-propanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (15Z,18Z)-hexacosa-15,18-dienoate

C35H65O10P (676.4315)


   

[1-hydroxy-3-[hydroxy-(3-hydroxy-2-octanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (11Z,14Z)-henicosa-11,14-dienoate

[1-hydroxy-3-[hydroxy-(3-hydroxy-2-octanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (11Z,14Z)-henicosa-11,14-dienoate

C35H65O10P (676.4315)


   

[1-hydroxy-3-[hydroxy-(3-hydroxy-2-pentanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (13Z,16Z)-tetracosa-13,16-dienoate

[1-hydroxy-3-[hydroxy-(3-hydroxy-2-pentanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (13Z,16Z)-tetracosa-13,16-dienoate

C35H65O10P (676.4315)


   

[1-hydroxy-3-[hydroxy-(3-hydroxy-2-nonanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (11Z,14Z)-icosa-11,14-dienoate

[1-hydroxy-3-[hydroxy-(3-hydroxy-2-nonanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (11Z,14Z)-icosa-11,14-dienoate

C35H65O10P (676.4315)


   

[1-[(2-decanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (9Z,12Z)-nonadeca-9,12-dienoate

[1-[(2-decanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (9Z,12Z)-nonadeca-9,12-dienoate

C35H65O10P (676.4315)


   

[1-hydroxy-3-[hydroxy-[3-hydroxy-2-[(Z)-tridec-9-enoyl]oxypropoxy]phosphoryl]oxypropan-2-yl] (Z)-hexadec-9-enoate

[1-hydroxy-3-[hydroxy-[3-hydroxy-2-[(Z)-tridec-9-enoyl]oxypropoxy]phosphoryl]oxypropan-2-yl] (Z)-hexadec-9-enoate

C35H65O10P (676.4315)


   

[1-[(2-dodecanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (9Z,12Z)-heptadeca-9,12-dienoate

[1-[(2-dodecanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (9Z,12Z)-heptadeca-9,12-dienoate

C35H65O10P (676.4315)


   

[1-hydroxy-3-[hydroxy-[3-hydroxy-2-[(Z)-tetradec-9-enoyl]oxypropoxy]phosphoryl]oxypropan-2-yl] (Z)-pentadec-9-enoate

[1-hydroxy-3-[hydroxy-[3-hydroxy-2-[(Z)-tetradec-9-enoyl]oxypropoxy]phosphoryl]oxypropan-2-yl] (Z)-pentadec-9-enoate

C35H65O10P (676.4315)


   

[1-hydroxy-3-[hydroxy-(3-hydroxy-2-undecanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (9Z,12Z)-octadeca-9,12-dienoate

[1-hydroxy-3-[hydroxy-(3-hydroxy-2-undecanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (9Z,12Z)-octadeca-9,12-dienoate

C35H65O10P (676.4315)


   

[1-hydroxy-3-[hydroxy-(3-hydroxy-2-tridecanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (9Z,12Z)-hexadeca-9,12-dienoate

[1-hydroxy-3-[hydroxy-(3-hydroxy-2-tridecanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (9Z,12Z)-hexadeca-9,12-dienoate

C35H65O10P (676.4315)


   

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-heptanoyloxypropan-2-yl] (13Z,16Z)-docosa-13,16-dienoate

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-heptanoyloxypropan-2-yl] (13Z,16Z)-docosa-13,16-dienoate

C35H65O10P (676.4315)


   

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-propanoyloxypropan-2-yl] (15Z,18Z)-hexacosa-15,18-dienoate

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-propanoyloxypropan-2-yl] (15Z,18Z)-hexacosa-15,18-dienoate

C35H65O10P (676.4315)


   

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-octanoyloxypropan-2-yl] (11Z,14Z)-henicosa-11,14-dienoate

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-octanoyloxypropan-2-yl] (11Z,14Z)-henicosa-11,14-dienoate

C35H65O10P (676.4315)


   

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-pentanoyloxypropan-2-yl] (13Z,16Z)-tetracosa-13,16-dienoate

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-pentanoyloxypropan-2-yl] (13Z,16Z)-tetracosa-13,16-dienoate

C35H65O10P (676.4315)


   

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-nonanoyloxypropan-2-yl] (11Z,14Z)-icosa-11,14-dienoate

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-nonanoyloxypropan-2-yl] (11Z,14Z)-icosa-11,14-dienoate

C35H65O10P (676.4315)


   

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-[(Z)-tetradec-9-enoyl]oxypropan-2-yl] (Z)-pentadec-9-enoate

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-[(Z)-tetradec-9-enoyl]oxypropan-2-yl] (Z)-pentadec-9-enoate

C35H65O10P (676.4315)


   

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-[(Z)-tridec-9-enoyl]oxypropan-2-yl] (Z)-hexadec-9-enoate

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-[(Z)-tridec-9-enoyl]oxypropan-2-yl] (Z)-hexadec-9-enoate

C35H65O10P (676.4315)


   

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-dodecanoyloxypropan-2-yl] (9Z,12Z)-heptadeca-9,12-dienoate

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-dodecanoyloxypropan-2-yl] (9Z,12Z)-heptadeca-9,12-dienoate

C35H65O10P (676.4315)


   

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-undecanoyloxypropan-2-yl] (9Z,12Z)-octadeca-9,12-dienoate

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-undecanoyloxypropan-2-yl] (9Z,12Z)-octadeca-9,12-dienoate

C35H65O10P (676.4315)


   

[1-decanoyloxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] (9Z,12Z)-nonadeca-9,12-dienoate

[1-decanoyloxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] (9Z,12Z)-nonadeca-9,12-dienoate

C35H65O10P (676.4315)


   

[1-phosphonooxy-3-[(Z)-tridec-9-enoyl]oxypropan-2-yl] (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate

[1-phosphonooxy-3-[(Z)-tridec-9-enoyl]oxypropan-2-yl] (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate

C38H61O8P (676.4104)


   

[1-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxy-3-phosphonooxypropan-2-yl] (3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoate

[1-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxy-3-phosphonooxypropan-2-yl] (3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoate

C38H61O8P (676.4104)


   

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-tridecanoyloxypropan-2-yl] (9Z,12Z)-hexadeca-9,12-dienoate

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-tridecanoyloxypropan-2-yl] (9Z,12Z)-hexadeca-9,12-dienoate

C35H65O10P (676.4315)


   

[(2R)-1-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-3-[(E)-tetradec-9-enoyl]oxypropan-2-yl] (E)-pentadec-9-enoate

[(2R)-1-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-3-[(E)-tetradec-9-enoyl]oxypropan-2-yl] (E)-pentadec-9-enoate

C35H65O10P (676.4315)


   

[2-[(4E,7E)-hexadeca-4,7-dienoyl]oxy-3-phosphonooxypropyl] (4E,7E,10E,13E,16E)-nonadeca-4,7,10,13,16-pentaenoate

[2-[(4E,7E)-hexadeca-4,7-dienoyl]oxy-3-phosphonooxypropyl] (4E,7E,10E,13E,16E)-nonadeca-4,7,10,13,16-pentaenoate

C38H61O8P (676.4104)


   

[(2R)-3-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-2-[(E)-tetradec-9-enoyl]oxypropyl] (E)-pentadec-9-enoate

[(2R)-3-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-2-[(E)-tetradec-9-enoyl]oxypropyl] (E)-pentadec-9-enoate

C35H65O10P (676.4315)


   

[1-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-3-tridecanoyloxypropan-2-yl] (4E,7E)-hexadeca-4,7-dienoate

[1-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-3-tridecanoyloxypropan-2-yl] (4E,7E)-hexadeca-4,7-dienoate

C35H65O10P (676.4315)


   

[(2S)-3-[[(2R)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-2-undecanoyloxypropyl] (9E,11E)-octadeca-9,11-dienoate

[(2S)-3-[[(2R)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-2-undecanoyloxypropyl] (9E,11E)-octadeca-9,11-dienoate

C35H65O10P (676.4315)


   

[2-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxy-3-phosphonooxypropyl] (10E,13E,16E)-nonadeca-10,13,16-trienoate

[2-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxy-3-phosphonooxypropyl] (10E,13E,16E)-nonadeca-10,13,16-trienoate

C38H61O8P (676.4104)


   

[(2R)-1-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-3-dodecanoyloxypropan-2-yl] (9E,12E)-heptadeca-9,12-dienoate

[(2R)-1-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-3-dodecanoyloxypropan-2-yl] (9E,12E)-heptadeca-9,12-dienoate

C35H65O10P (676.4315)


   

[(2S)-3-[[(2R)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-2-undecanoyloxypropyl] (9E,12E)-octadeca-9,12-dienoate

[(2S)-3-[[(2R)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-2-undecanoyloxypropyl] (9E,12E)-octadeca-9,12-dienoate

C35H65O10P (676.4315)


   

[(2R)-1-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-3-undecanoyloxypropan-2-yl] (2E,4E)-octadeca-2,4-dienoate

[(2R)-1-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-3-undecanoyloxypropan-2-yl] (2E,4E)-octadeca-2,4-dienoate

C35H65O10P (676.4315)


   

[(2R)-1-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-3-undecanoyloxypropan-2-yl] (9E,12E)-octadeca-9,12-dienoate

[(2R)-1-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-3-undecanoyloxypropan-2-yl] (9E,12E)-octadeca-9,12-dienoate

C35H65O10P (676.4315)


   

[(2R)-1-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-3-undecanoyloxypropan-2-yl] (6E,9E)-octadeca-6,9-dienoate

[(2R)-1-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-3-undecanoyloxypropan-2-yl] (6E,9E)-octadeca-6,9-dienoate

C35H65O10P (676.4315)


   

[2-[(9E,11E,13E)-hexadeca-9,11,13-trienoyl]oxy-3-phosphonooxypropyl] (7E,10E,13E,16E)-nonadeca-7,10,13,16-tetraenoate

[2-[(9E,11E,13E)-hexadeca-9,11,13-trienoyl]oxy-3-phosphonooxypropyl] (7E,10E,13E,16E)-nonadeca-7,10,13,16-tetraenoate

C38H61O8P (676.4104)


   

[1-[(E)-tridec-8-enoyl]oxy-3-[(2R,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoate

[1-[(E)-tridec-8-enoyl]oxy-3-[(2R,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoate

C38H60O10 (676.4186)


   

[2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-3-phosphonooxypropyl] (7E,9E)-nonadeca-7,9-dienoate

[2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-3-phosphonooxypropyl] (7E,9E)-nonadeca-7,9-dienoate

C38H61O8P (676.4104)


   

[(2S)-3-[[(2R)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-2-undecanoyloxypropyl] (2E,4E)-octadeca-2,4-dienoate

[(2S)-3-[[(2R)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-2-undecanoyloxypropyl] (2E,4E)-octadeca-2,4-dienoate

C35H65O10P (676.4315)


   

[(2R)-1-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-3-undecanoyloxypropan-2-yl] (9E,11E)-octadeca-9,11-dienoate

[(2R)-1-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-3-undecanoyloxypropan-2-yl] (9E,11E)-octadeca-9,11-dienoate

C35H65O10P (676.4315)


   

[(2S)-3-[[(2R)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-2-dodecanoyloxypropyl] (9E,12E)-heptadeca-9,12-dienoate

[(2S)-3-[[(2R)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-2-dodecanoyloxypropyl] (9E,12E)-heptadeca-9,12-dienoate

C35H65O10P (676.4315)


   

[(2S)-3-[[(2R)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-2-undecanoyloxypropyl] (6E,9E)-octadeca-6,9-dienoate

[(2S)-3-[[(2R)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-2-undecanoyloxypropyl] (6E,9E)-octadeca-6,9-dienoate

C35H65O10P (676.4315)


   

1-(9Z,12Z-heptadecadienoyl)-2-dodecanoyl-glycero-3-phospho-(1-sn-glycerol)

1-(9Z,12Z-heptadecadienoyl)-2-dodecanoyl-glycero-3-phospho-(1-sn-glycerol)

C35H65O10P (676.4315)


   

1-dodecanoyl-2-(9Z,12Z-heptadecadienoyl)-glycero-3-phospho-(1-sn-glycerol)

1-dodecanoyl-2-(9Z,12Z-heptadecadienoyl)-glycero-3-phospho-(1-sn-glycerol)

C35H65O10P (676.4315)


   

Hygrolidin

Hygrolidin

C37H56O11 (676.3822)


A macrolide consisting resulting from the formal lactonisation of the carboxy group of (2E,4E,6R,7S,8S,10E,12E,14S,15R,16S,17R,18S)-18-[(2R,4R,5S,6R)-4-{[(2E)-3-carboxyprop-2-enoyl]oxy}-2-hydroxy-5,6-dimethyltetrahydro-2H-pyran-2-yl]-7,15,17-trihydroxy-14-methoxy-2,4,6,8,10,16-hexamethylnonadeca-2,4,10,12-tetraenoic acid with the hydroxy group at position 15. It is active against SV40 tumour cells, and inhibits the growth of solid tumour-derived cell lines such as DLD-1 human colon cancer cells with increased cells in G1 and S phases.

   

phosphatidylserine 28:1(1-)

phosphatidylserine 28:1(1-)

C34H63NO10P (676.4189)


A 3-sn-phosphatidyl-L-serine(1-) in which the acyl groups at C-1 and C-2 contain 28 carbons in total and 1 double bond.

   

Cimiracemoside F

Cimiracemoside F

C37H56O11 (676.3822)


A natural product found in Actaea racemosa.

   

MGDG O-29:7;O

MGDG O-29:7;O

C38H60O10 (676.4186)


   
   
   
   
   
   
   

PA O-20:0/12:3;O3

PA O-20:0/12:3;O3

C35H65O10P (676.4315)


   
   

PA P-20:0/12:2;O3

PA P-20:0/12:2;O3

C35H65O10P (676.4315)


   

PA 14:0/18:2;O2

PA 14:0/18:2;O2

C35H65O10P (676.4315)


   

PA 14:1/18:1;O2

PA 14:1/18:1;O2

C35H65O10P (676.4315)


   

PA 20:0/11:3;O3

PA 20:0/11:3;O3

C34H61O11P (676.3951)


   

PA 20:0/12:2;O2

PA 20:0/12:2;O2

C35H65O10P (676.4315)


   

PA 20:5/13:4;O2

PA 20:5/13:4;O2

C36H53O10P (676.3376)


   

PA 22:5/12:3;O

PA 22:5/12:3;O

C37H57O9P (676.374)


   
   
   
   
   
   

PG O-16:0/13:3;O

PG O-16:0/13:3;O

C35H65O10P (676.4315)


   
   
   
   

PG P-16:0/12:3;O2

PG P-16:0/12:3;O2

C34H61O11P (676.3951)


   

PG P-16:1/11:3;O3

PG P-16:1/11:3;O3

C33H57O12P (676.3587)


   

PG P-16:1/12:2;O2

PG P-16:1/12:2;O2

C34H61O11P (676.3951)


   

PG P-18:0/11:2;O

PG P-18:0/11:2;O

C35H65O10P (676.4315)


   

PG P-20:0/8:3;O2

PG P-20:0/8:3;O2

C34H61O11P (676.3951)


   

PG P-20:1/7:3;O3

PG P-20:1/7:3;O3

C33H57O12P (676.3587)


   

PG P-20:1/8:2;O2

PG P-20:1/8:2;O2

C34H61O11P (676.3951)


   

PG P-20:1/9:1;O

PG P-20:1/9:1;O

C35H65O10P (676.4315)


   

PG 14:0/13:4;O2

PG 14:0/13:4;O2

C33H57O12P (676.3587)


   

PG 14:1/13:3;O2

PG 14:1/13:3;O2

C33H57O12P (676.3587)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

PEth 32:8;O

PEth 32:8;O

C37H57O9P (676.374)


   
   
   
   

ST 27:0;O8;GlcA

ST 27:0;O8;GlcA

C33H56O14 (676.367)


   

ST 28:0;O8;Hex

ST 28:0;O8;Hex

C34H60O13 (676.4034)


   

methyl (1s,12r,14r,18s)-12-[(1r,15s,17s,18s)-17-ethyl-7-methoxy-3,13-diazapentacyclo[13.3.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁸]nonadeca-2(10),4,6,8-tetraen-6-yl]-15-ethylidene-18-(hydroxymethyl)-17-methyl-10,17-diazatetracyclo[12.3.1.0³,¹¹.0⁴,⁹]octadeca-3(11),4,6,8-tetraene-18-carboxylate

methyl (1s,12r,14r,18s)-12-[(1r,15s,17s,18s)-17-ethyl-7-methoxy-3,13-diazapentacyclo[13.3.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁸]nonadeca-2(10),4,6,8-tetraen-6-yl]-15-ethylidene-18-(hydroxymethyl)-17-methyl-10,17-diazatetracyclo[12.3.1.0³,¹¹.0⁴,⁹]octadeca-3(11),4,6,8-tetraene-18-carboxylate

C42H52N4O4 (676.3988)


   

methyl (1s,12s,14s,15e,18s)-12-[(1s,9s,12s,13s,15r,20r)-12-ethyl-8-methyl-14-oxa-8,17-diazahexacyclo[10.7.1.0¹,⁹.0²,⁷.0¹³,¹⁵.0¹⁷,²⁰]icosa-2,4,6-trien-4-yl]-15-ethylidene-18-(hydroxymethyl)-17-methyl-10,17-diazatetracyclo[12.3.1.0³,¹¹.0⁴,⁹]octadeca-3(11),4,6,8-tetraene-18-carboxylate

methyl (1s,12s,14s,15e,18s)-12-[(1s,9s,12s,13s,15r,20r)-12-ethyl-8-methyl-14-oxa-8,17-diazahexacyclo[10.7.1.0¹,⁹.0²,⁷.0¹³,¹⁵.0¹⁷,²⁰]icosa-2,4,6-trien-4-yl]-15-ethylidene-18-(hydroxymethyl)-17-methyl-10,17-diazatetracyclo[12.3.1.0³,¹¹.0⁴,⁹]octadeca-3(11),4,6,8-tetraene-18-carboxylate

C42H52N4O4 (676.3988)


   

1-(2,6-dihydroxy-6-methyl-3-oxohept-4-en-2-yl)-2-hydroxy-3a,6,6,9b,11a-pentamethyl-8-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3bh,4h,9ah,11h-cyclopenta[a]phenanthrene-7,10-dione

1-(2,6-dihydroxy-6-methyl-3-oxohept-4-en-2-yl)-2-hydroxy-3a,6,6,9b,11a-pentamethyl-8-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3bh,4h,9ah,11h-cyclopenta[a]phenanthrene-7,10-dione

C36H52O12 (676.3459)


   

2-hydroxy-3-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}propyl octadeca-9,12,15-trienoate

2-hydroxy-3-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}propyl octadeca-9,12,15-trienoate

C33H56O14 (676.367)


   

(1s,4s,5s,6s,8r,10r,11r,13s,17r,18r,19r,22s)-6-hydroxy-22-isopropyl-4,9,9,13,17-pentamethyl-10-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-20-oxahexacyclo[17.2.2.0¹,¹⁸.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tricos-14-en-11-yl acetate

(1s,4s,5s,6s,8r,10r,11r,13s,17r,18r,19r,22s)-6-hydroxy-22-isopropyl-4,9,9,13,17-pentamethyl-10-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-20-oxahexacyclo[17.2.2.0¹,¹⁸.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tricos-14-en-11-yl acetate

C38H60O10 (676.4186)


   

(2r,3r,4s,5s,6r)-3-(acetyloxy)-2-[(acetyloxy)methyl]-5-[(2-methylpropanoyl)oxy]-6-[(2r,3s)-2,3,4-trihydroxybutoxy]oxan-4-yl hexadecanoate

(2r,3r,4s,5s,6r)-3-(acetyloxy)-2-[(acetyloxy)methyl]-5-[(2-methylpropanoyl)oxy]-6-[(2r,3s)-2,3,4-trihydroxybutoxy]oxan-4-yl hexadecanoate

C34H60O13 (676.4034)


   

5-{[7-(acetyloxy)-1-[2-hydroxy-6-(2-hydroxypropan-2-yl)oxan-3-yl]-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-8-yl]oxy}-3-hydroxy-3-methyl-5-oxopentanoic acid

5-{[7-(acetyloxy)-1-[2-hydroxy-6-(2-hydroxypropan-2-yl)oxan-3-yl]-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-8-yl]oxy}-3-hydroxy-3-methyl-5-oxopentanoic acid

C38H60O10 (676.4186)


   

(6s,9s,12s,15s,20as)-15-benzyl-6-[(2s)-butan-2-yl]-1,4,7,10,13-pentahydroxy-12-[(4-hydroxyphenyl)methyl]-9-isopropyl-3h,6h,9h,12h,15h,18h,19h,20h,20ah-pyrrolo[1,2-a]1,4,7,10,13,16-hexaazacyclooctadecan-16-one

(6s,9s,12s,15s,20as)-15-benzyl-6-[(2s)-butan-2-yl]-1,4,7,10,13-pentahydroxy-12-[(4-hydroxyphenyl)methyl]-9-isopropyl-3h,6h,9h,12h,15h,18h,19h,20h,20ah-pyrrolo[1,2-a]1,4,7,10,13,16-hexaazacyclooctadecan-16-one

C36H48N6O7 (676.3584)


   

2,3-dihydroxy-2-methyl-6-[6,9,14-tris(acetyloxy)-7,7,12,16-tetramethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-15-yl]heptan-4-yl acetate

2,3-dihydroxy-2-methyl-6-[6,9,14-tris(acetyloxy)-7,7,12,16-tetramethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-15-yl]heptan-4-yl acetate

C38H60O10 (676.4186)


   

(1s,1'r,2r,3'r,4s,4'r,5r,5'r,6'r,10's,12's,13's,16'r,18's,21'r)-4-hydroxy-4',5,6',12',17',17'-hexamethyl-18'-{[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}-3,6,9'-trioxaspiro[bicyclo[3.1.0]hexane-2,8'-hexacyclo[11.9.0.0¹,²¹.0⁴,¹².0⁵,¹⁰.0¹⁶,²¹]docosan]-3'-yl acetate

(1s,1'r,2r,3'r,4s,4'r,5r,5'r,6'r,10's,12's,13's,16'r,18's,21'r)-4-hydroxy-4',5,6',12',17',17'-hexamethyl-18'-{[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}-3,6,9'-trioxaspiro[bicyclo[3.1.0]hexane-2,8'-hexacyclo[11.9.0.0¹,²¹.0⁴,¹².0⁵,¹⁰.0¹⁶,²¹]docosan]-3'-yl acetate

C37H56O11 (676.3822)


   

(3as,7as)-1-[(2s)-2-{[1,2-dihydroxy-3-(4-hydroxyphenyl)propylidene]amino}-3-phenylpropanoyl]-6-hydroxy-n-{4-[n-(3-methylbut-2-en-1-yl)carbamimidamido]butyl}-octahydroindole-2-carboximidic acid

(3as,7as)-1-[(2s)-2-{[1,2-dihydroxy-3-(4-hydroxyphenyl)propylidene]amino}-3-phenylpropanoyl]-6-hydroxy-n-{4-[n-(3-methylbut-2-en-1-yl)carbamimidamido]butyl}-octahydroindole-2-carboximidic acid

C37H52N6O6 (676.3948)


   

2-[(2-{[3,5-dihydroxy-2-(hydroxymethyl)-6-[(2,6,10-trimethyldodeca-2,6,10-trien-1-yl)oxy]oxan-4-yl]oxy}-4,5-dihydroxy-6-methyloxan-3-yl)oxy]-6-methyloxane-3,4,5-triol

2-[(2-{[3,5-dihydroxy-2-(hydroxymethyl)-6-[(2,6,10-trimethyldodeca-2,6,10-trien-1-yl)oxy]oxan-4-yl]oxy}-4,5-dihydroxy-6-methyloxan-3-yl)oxy]-6-methyloxane-3,4,5-triol

C33H56O14 (676.367)


   

(2s)-2-hydroxy-3-{[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-({[(2s,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}propyl (9z,12z,15z)-octadeca-9,12,15-trienoate

(2s)-2-hydroxy-3-{[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-({[(2s,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}propyl (9z,12z,15z)-octadeca-9,12,15-trienoate

C33H56O14 (676.367)


   

5-[(4,5-dihydroxy-4,6-dimethyloxan-2-yl)oxy]-4-hydroxy-6-methyloxan-2-yl 2-[4,10-dihydroxy-8-(3-hydroxypentan-2-yl)-3,5,9,11-tetramethyl-1,7-dioxaspiro[5.5]undecan-2-yl]propanoate

5-[(4,5-dihydroxy-4,6-dimethyloxan-2-yl)oxy]-4-hydroxy-6-methyloxan-2-yl 2-[4,10-dihydroxy-8-(3-hydroxypentan-2-yl)-3,5,9,11-tetramethyl-1,7-dioxaspiro[5.5]undecan-2-yl]propanoate

C34H60O13 (676.4034)


   

(2s,4r,5s,6r)-5-{[(2s,4s,5r,6r)-4,5-dihydroxy-4,6-dimethyloxan-2-yl]oxy}-4-hydroxy-6-methyloxan-2-yl (2s)-2-[(2s,3r,4s,5r,6s,8r,9r,10s,11s)-4,10-dihydroxy-8-[(2s,3s)-3-hydroxypentan-2-yl]-3,5,9,11-tetramethyl-1,7-dioxaspiro[5.5]undecan-2-yl]propanoate

(2s,4r,5s,6r)-5-{[(2s,4s,5r,6r)-4,5-dihydroxy-4,6-dimethyloxan-2-yl]oxy}-4-hydroxy-6-methyloxan-2-yl (2s)-2-[(2s,3r,4s,5r,6s,8r,9r,10s,11s)-4,10-dihydroxy-8-[(2s,3s)-3-hydroxypentan-2-yl]-3,5,9,11-tetramethyl-1,7-dioxaspiro[5.5]undecan-2-yl]propanoate

C34H60O13 (676.4034)


   

(1r,4s,5s,6s,8s,10r,11r,13s,17r,18r,19s,22s)-6-hydroxy-22-isopropyl-4,9,9,13,17-pentamethyl-10-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-20-oxahexacyclo[17.2.2.0¹,¹⁸.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tricos-14-en-11-yl acetate

(1r,4s,5s,6s,8s,10r,11r,13s,17r,18r,19s,22s)-6-hydroxy-22-isopropyl-4,9,9,13,17-pentamethyl-10-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-20-oxahexacyclo[17.2.2.0¹,¹⁸.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tricos-14-en-11-yl acetate

C38H60O10 (676.4186)


   

3-(acetyloxy)-2-[(acetyloxy)methyl]-5-[(2-methylpropanoyl)oxy]-6-(2,3,4-trihydroxybutoxy)oxan-4-yl hexadecanoate

3-(acetyloxy)-2-[(acetyloxy)methyl]-5-[(2-methylpropanoyl)oxy]-6-(2,3,4-trihydroxybutoxy)oxan-4-yl hexadecanoate

C34H60O13 (676.4034)


   

1,6,10-farnesatrien-3-ol; (s)-form,o-[alpha-l-rhamnopyranosyl-(1→4)-alpha-l-rhamnopyranosyl-(1→2)-beta-d-glucopyranoside]

NA

C33H56O14 (676.367)


{"Ingredient_id": "HBIN001741","Ingredient_name": "1,6,10-farnesatrien-3-ol; (s)-form,o-[alpha-l-rhamnopyranosyl-(1\u21924)-alpha-l-rhamnopyranosyl-(1\u21922)-beta-d-glucopyranoside]","Alias": "NA","Ingredient_formula": "C33H56O14","Ingredient_Smile": "NA","Ingredient_weight": "0","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "9497","PubChem_id": "NA","DrugBank_id": "NA"}

   

1α,3β-hydroxyimberbicacid-23-o-α-l-4-acetyl-rhamnopyranoside

NA

C38H60O10 (676.4186)


{"Ingredient_id": "HBIN002286","Ingredient_name": "1\u03b1,3\u03b2-hydroxyimberbicacid-23-o-\u03b1-l-4-acetyl-rhamnopyranoside","Alias": "NA","Ingredient_formula": "C38H60O10","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10225","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

23-o-acetylshengmanol-3-o-alpha-l-arabinopyranoside

23-o-acetylshengmanol 3-o-α-l-arabinopyrano-side

C38H60O10 (676.4186)


{"Ingredient_id": "HBIN004141","Ingredient_name": "23-o-acetylshengmanol-3-o-alpha-l-arabinopyranoside","Alias": "23-o-acetylshengmanol 3-o-\u03b1-l-arabinopyrano-side","Ingredient_formula": "C38H60O10","Ingredient_Smile": "CC(CC(C)(C1C(O1)(C)C)OC(=O)C)C2C(=O)C(C3(C2(CCC45C3CCC6C4(C5)CCC(C6(C)C)OC7C(C(C(CO7)O)O)O)C)C)O","Ingredient_weight": "676.9 g/mol","OB_score": "21.08968048","CAS_id": "NA","SymMap_id": "SMIT12813;SMIT14165","TCMID_id": "512","TCMSP_id": "MOL011994","TCM_ID_id": "NA","PubChem_id": "12045947","DrugBank_id": "NA"}

   

acetylacetol 3-o-arabinoside

NA

C37H56O11 (676.3822)


{"Ingredient_id": "HBIN014443","Ingredient_name": "acetylacetol 3-o-arabinoside","Alias": "NA","Ingredient_formula": "C37H56O11","Ingredient_Smile": "NA","Ingredient_weight": "676.843","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "7225","PubChem_id": "NA","DrugBank_id": "NA"}

   

α,β-digalactosyl-α'-linolenic-glyceride

NA

C33H56O14 (676.367)


{"Ingredient_id": "HBIN015399","Ingredient_name": "\u03b1,\u03b2-digalactosyl-\u03b1'-linolenic-glyceride","Alias": "NA","Ingredient_formula": "C33H56O14","Ingredient_Smile": "CCC=CCC=CCC=CCCCCCCCC(=O)OCC(COC1C(C(C(C(O1)CO)O)O)O)OC2C(C(C(C(O2)CO)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "5508","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

21,22-dihydroxy-1,6,6,15,17,20,20-heptamethyl-7-[(3,4,5-trihydroxyoxan-2-yl)oxy]-19,23-dioxaheptacyclo[13.10.0.0²,¹².0⁵,¹⁰.0¹⁰,¹².0¹⁶,²⁴.0¹⁸,²²]pentacos-2-en-14-yl acetate

21,22-dihydroxy-1,6,6,15,17,20,20-heptamethyl-7-[(3,4,5-trihydroxyoxan-2-yl)oxy]-19,23-dioxaheptacyclo[13.10.0.0²,¹².0⁵,¹⁰.0¹⁰,¹².0¹⁶,²⁴.0¹⁸,²²]pentacos-2-en-14-yl acetate

C37H56O11 (676.3822)


   

(2r,3r,4s,5r,6r)-2-{[(2s,3s,4s,5s,6r)-6-{[(1s,3as,3br,5as,7s,9as,9bs,10s,11s,11as)-3a,10,11-trihydroxy-1-[(1r)-1-hydroxyethyl]-9a,11a-dimethyl-tetradecahydrocyclopenta[a]phenanthren-7-yl]oxy}-4,5-dihydroxy-2-methyloxan-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5r,6r)-2-{[(2s,3s,4s,5s,6r)-6-{[(1s,3as,3br,5as,7s,9as,9bs,10s,11s,11as)-3a,10,11-trihydroxy-1-[(1r)-1-hydroxyethyl]-9a,11a-dimethyl-tetradecahydrocyclopenta[a]phenanthren-7-yl]oxy}-4,5-dihydroxy-2-methyloxan-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C33H56O14 (676.367)


   

7-hydroxy-3'-(2-hydroxypropan-2-yl)-4,6,12,17,17-pentamethyl-18-[(3,4,5-trihydroxyoxan-2-yl)oxy]-9-oxaspiro[hexacyclo[11.9.0.0¹,²¹.0⁴,¹².0⁵,¹⁰.0¹⁶,²¹]docosane-8,2'-oxiran]-13-en-3-yl acetate

7-hydroxy-3'-(2-hydroxypropan-2-yl)-4,6,12,17,17-pentamethyl-18-[(3,4,5-trihydroxyoxan-2-yl)oxy]-9-oxaspiro[hexacyclo[11.9.0.0¹,²¹.0⁴,¹².0⁵,¹⁰.0¹⁶,²¹]docosane-8,2'-oxiran]-13-en-3-yl acetate

C37H56O11 (676.3822)


   
   

1,3-bis(acetyloxy)-7-(3-ethenyl-4-hydroxybut-2-en-1-yl)-5,10-dihydroxy-7,8-dimethyl-1h,3h,5h,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-9-yl tetradecanoate

1,3-bis(acetyloxy)-7-(3-ethenyl-4-hydroxybut-2-en-1-yl)-5,10-dihydroxy-7,8-dimethyl-1h,3h,5h,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-9-yl tetradecanoate

C38H60O10 (676.4186)


   

(3s,6s,9s,12s,15s,18s)-15-benzyl-8,11,17-trihydroxy-9-[(1s)-1-hydroxyethyl]-6-(hydroxymethyl)-3-isopropyl-13-methyl-12,18-bis(2-methylpropyl)-1,4-dioxa-7,10,13,16-tetraazacyclooctadeca-7,10,16-triene-2,5,14-trione

(3s,6s,9s,12s,15s,18s)-15-benzyl-8,11,17-trihydroxy-9-[(1s)-1-hydroxyethyl]-6-(hydroxymethyl)-3-isopropyl-13-methyl-12,18-bis(2-methylpropyl)-1,4-dioxa-7,10,13,16-tetraazacyclooctadeca-7,10,16-triene-2,5,14-trione

C34H52N4O10 (676.3683)


   

4,5-bis(acetyloxy)-6-{[2-(hexadecyloxy)-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy}-2-methyloxan-3-yl acetate

4,5-bis(acetyloxy)-6-{[2-(hexadecyloxy)-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy}-2-methyloxan-3-yl acetate

C34H60O13 (676.4034)


   

(5as,5br,7ar,9r,10r,11as,11bs)-11a-(hydroxymethyl)-3-isopropyl-3a,5a,5b,8,8-pentamethyl-1-oxo-9-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2h,3h,4h,5h,6h,7h,7ah,9h,10h,11h,11bh,12h,13h-cyclopenta[a]chrysen-10-yl acetate

(5as,5br,7ar,9r,10r,11as,11bs)-11a-(hydroxymethyl)-3-isopropyl-3a,5a,5b,8,8-pentamethyl-1-oxo-9-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2h,3h,4h,5h,6h,7h,7ah,9h,10h,11h,11bh,12h,13h-cyclopenta[a]chrysen-10-yl acetate

C38H60O10 (676.4186)


   

(2r,4r,5s,6r)-3,3,4,5-tetrahydroxy-2-propoxy-6-({[(2s,3s,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-4-yl (9z,12z,15z)-octadeca-9,12,15-trienoate

(2r,4r,5s,6r)-3,3,4,5-tetrahydroxy-2-propoxy-6-({[(2s,3s,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-4-yl (9z,12z,15z)-octadeca-9,12,15-trienoate

C33H56O14 (676.367)


   

6-hydroxy-22-isopropyl-4,9,9,13,17-pentamethyl-10-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-20-oxahexacyclo[17.2.2.0¹,¹⁸.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tricos-14-en-11-yl acetate

6-hydroxy-22-isopropyl-4,9,9,13,17-pentamethyl-10-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-20-oxahexacyclo[17.2.2.0¹,¹⁸.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tricos-14-en-11-yl acetate

C38H60O10 (676.4186)


   

3-(acetyloxy)-2-[(acetyloxy)methyl]-5-(butanoyloxy)-6-(2,3,4-trihydroxybutoxy)oxan-4-yl hexadecanoate

3-(acetyloxy)-2-[(acetyloxy)methyl]-5-(butanoyloxy)-6-(2,3,4-trihydroxybutoxy)oxan-4-yl hexadecanoate

C34H60O13 (676.4034)


   

(1s,3r,3's,4r,5r,6s,7r,8r,10s,12s,16r,18s,21r)-7-hydroxy-3'-(2-hydroxypropan-2-yl)-4,6,12,17,17-pentamethyl-18-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}-9-oxaspiro[hexacyclo[11.9.0.0¹,²¹.0⁴,¹².0⁵,¹⁰.0¹⁶,²¹]docosane-8,2'-oxiran]-13-en-3-yl acetate

(1s,3r,3's,4r,5r,6s,7r,8r,10s,12s,16r,18s,21r)-7-hydroxy-3'-(2-hydroxypropan-2-yl)-4,6,12,17,17-pentamethyl-18-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}-9-oxaspiro[hexacyclo[11.9.0.0¹,²¹.0⁴,¹².0⁵,¹⁰.0¹⁶,²¹]docosane-8,2'-oxiran]-13-en-3-yl acetate

C37H56O11 (676.3822)


   

(1s,1'r,2r,3'r,4s,4'r,5r,5'r,6'r,10's,12's,13's,16'r,18's,21'r)-4-hydroxy-4',5,6',12',17',17'-hexamethyl-18'-{[(2s,3s,4r,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}-3,6,9'-trioxaspiro[bicyclo[3.1.0]hexane-2,8'-hexacyclo[11.9.0.0¹,²¹.0⁴,¹².0⁵,¹⁰.0¹⁶,²¹]docosan]-3'-yl acetate

(1s,1'r,2r,3'r,4s,4'r,5r,5'r,6'r,10's,12's,13's,16'r,18's,21'r)-4-hydroxy-4',5,6',12',17',17'-hexamethyl-18'-{[(2s,3s,4r,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}-3,6,9'-trioxaspiro[bicyclo[3.1.0]hexane-2,8'-hexacyclo[11.9.0.0¹,²¹.0⁴,¹².0⁵,¹⁰.0¹⁶,²¹]docosan]-3'-yl acetate

C37H56O11 (676.3822)


   

(3s,3ar,5as,5br,7ar,9r,10r,11as,11bs)-11a-(hydroxymethyl)-3-isopropyl-3a,5a,5b,8,8-pentamethyl-1-oxo-9-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2h,3h,4h,5h,6h,7h,7ah,9h,10h,11h,11bh,12h,13h-cyclopenta[a]chrysen-10-yl acetate

(3s,3ar,5as,5br,7ar,9r,10r,11as,11bs)-11a-(hydroxymethyl)-3-isopropyl-3a,5a,5b,8,8-pentamethyl-1-oxo-9-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2h,3h,4h,5h,6h,7h,7ah,9h,10h,11h,11bh,12h,13h-cyclopenta[a]chrysen-10-yl acetate

C38H60O10 (676.4186)


   

(1r,3s,5s,6ar,7r,8r,9s,10s,10ar)-1,3-bis(acetyloxy)-7-[(2z)-3-ethenyl-4-hydroxybut-2-en-1-yl]-5,10-dihydroxy-7,8-dimethyl-1h,3h,5h,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-9-yl tetradecanoate

(1r,3s,5s,6ar,7r,8r,9s,10s,10ar)-1,3-bis(acetyloxy)-7-[(2z)-3-ethenyl-4-hydroxybut-2-en-1-yl]-5,10-dihydroxy-7,8-dimethyl-1h,3h,5h,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-9-yl tetradecanoate

C38H60O10 (676.4186)


   

13-(acetyloxy)-9-hydroperoxy-1,6-dihydroxy-8-(hydroxymethyl)-4,12,12,15-tetramethyl-5-oxotetracyclo[8.5.0.0²,⁶.0¹¹,¹³]pentadeca-3,7-dien-14-yl hexadecanoate

13-(acetyloxy)-9-hydroperoxy-1,6-dihydroxy-8-(hydroxymethyl)-4,12,12,15-tetramethyl-5-oxotetracyclo[8.5.0.0²,⁶.0¹¹,¹³]pentadeca-3,7-dien-14-yl hexadecanoate

C38H60O10 (676.4186)


   

5-amino-2-({1-hydroxy-27-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]octacosa-2,4,6,8,10,12,14,16,18,20,22,24-dodecaen-1-ylidene}amino)pentanoic acid

5-amino-2-({1-hydroxy-27-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]octacosa-2,4,6,8,10,12,14,16,18,20,22,24-dodecaen-1-ylidene}amino)pentanoic acid

C39H52N2O8 (676.3723)


   

2-hydroxy-4-(2-hydroxy-6-pentadecyl-4-{[(2s,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}benzoyloxy)-6-methylbenzoic acid

2-hydroxy-4-(2-hydroxy-6-pentadecyl-4-{[(2s,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}benzoyloxy)-6-methylbenzoic acid

C36H52O12 (676.3459)


   

(2r,3r,4s,5s,6r)-3-(acetyloxy)-2-[(acetyloxy)methyl]-5-(butanoyloxy)-6-[(2r,3s)-2,3,4-trihydroxybutoxy]oxan-4-yl hexadecanoate

(2r,3r,4s,5s,6r)-3-(acetyloxy)-2-[(acetyloxy)methyl]-5-(butanoyloxy)-6-[(2r,3s)-2,3,4-trihydroxybutoxy]oxan-4-yl hexadecanoate

C34H60O13 (676.4034)


   

(3r,3ar,5as,5br,7ar,9r,10r,11as,11bs)-11a-(hydroxymethyl)-3-isopropyl-3a,5a,5b,8,8-pentamethyl-1-oxo-9-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2h,3h,4h,5h,6h,7h,7ah,9h,10h,11h,11bh,12h,13h-cyclopenta[a]chrysen-10-yl acetate

(3r,3ar,5as,5br,7ar,9r,10r,11as,11bs)-11a-(hydroxymethyl)-3-isopropyl-3a,5a,5b,8,8-pentamethyl-1-oxo-9-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2h,3h,4h,5h,6h,7h,7ah,9h,10h,11h,11bh,12h,13h-cyclopenta[a]chrysen-10-yl acetate

C38H60O10 (676.4186)


   

(2r,3r,4s,5s,6r)-2-{[(2s,3s,4s,5s,6r)-6-{[(1s,3as,3br,7s,9as,9bs,10s,11s,11as)-3a,10,11-trihydroxy-1-(1-hydroxyethyl)-9a,11a-dimethyl-tetradecahydrocyclopenta[a]phenanthren-7-yl]oxy}-4,5-dihydroxy-2-methyloxan-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(2s,3s,4s,5s,6r)-6-{[(1s,3as,3br,7s,9as,9bs,10s,11s,11as)-3a,10,11-trihydroxy-1-(1-hydroxyethyl)-9a,11a-dimethyl-tetradecahydrocyclopenta[a]phenanthren-7-yl]oxy}-4,5-dihydroxy-2-methyloxan-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C33H56O14 (676.367)


   

2-hydroxy-4-(2-hydroxy-6-pentadecyl-4-{[(2s,3r,4s,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}benzoyloxy)-6-methylbenzoic acid

2-hydroxy-4-(2-hydroxy-6-pentadecyl-4-{[(2s,3r,4s,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}benzoyloxy)-6-methylbenzoic acid

C36H52O12 (676.3459)


   

2-hydroxy-4-(2-hydroxy-6-pentadecyl-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}benzoyloxy)-6-methylbenzoic acid

2-hydroxy-4-(2-hydroxy-6-pentadecyl-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}benzoyloxy)-6-methylbenzoic acid

C36H52O12 (676.3459)


   

6,7,34,35-tetrahydroxy-5,33-bis(hydroxymethyl)-12,29-dimethyl-2,4,9,14,30,32-hexaoxatetracyclo[29.4.0.0³,⁸.0¹¹,¹⁵]pentatriacontane-10,13-dione

6,7,34,35-tetrahydroxy-5,33-bis(hydroxymethyl)-12,29-dimethyl-2,4,9,14,30,32-hexaoxatetracyclo[29.4.0.0³,⁸.0¹¹,¹⁵]pentatriacontane-10,13-dione

C33H56O14 (676.367)


   

4,5-dihydroxy-6-({21-hydroxy-22-methoxy-1,6,6,15,17,20,20-heptamethyl-19,23-dioxaheptacyclo[13.10.0.0²,¹².0⁵,¹⁰.0¹⁰,¹².0¹⁶,²⁴.0¹⁸,²²]pentacosan-7-yl}oxy)oxan-3-yl acetate

4,5-dihydroxy-6-({21-hydroxy-22-methoxy-1,6,6,15,17,20,20-heptamethyl-19,23-dioxaheptacyclo[13.10.0.0²,¹².0⁵,¹⁰.0¹⁰,¹².0¹⁶,²⁴.0¹⁸,²²]pentacosan-7-yl}oxy)oxan-3-yl acetate

C38H60O10 (676.4186)


   

(1r,2s,6r,9r,10r,11r,13s,14r,15r)-13-(acetyloxy)-9-hydroperoxy-1,6-dihydroxy-8-(hydroxymethyl)-4,12,12,15-tetramethyl-5-oxotetracyclo[8.5.0.0²,⁶.0¹¹,¹³]pentadeca-3,7-dien-14-yl hexadecanoate

(1r,2s,6r,9r,10r,11r,13s,14r,15r)-13-(acetyloxy)-9-hydroperoxy-1,6-dihydroxy-8-(hydroxymethyl)-4,12,12,15-tetramethyl-5-oxotetracyclo[8.5.0.0²,⁶.0¹¹,¹³]pentadeca-3,7-dien-14-yl hexadecanoate

C38H60O10 (676.4186)


   

(1r,2r,3as,3bs,9ar,9br,11ar)-1-[(2r,4e)-2,6-dihydroxy-6-methyl-3-oxohept-4-en-2-yl]-2-hydroxy-3a,6,6,9b,11a-pentamethyl-8-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3bh,4h,9ah,11h-cyclopenta[a]phenanthrene-7,10-dione

(1r,2r,3as,3bs,9ar,9br,11ar)-1-[(2r,4e)-2,6-dihydroxy-6-methyl-3-oxohept-4-en-2-yl]-2-hydroxy-3a,6,6,9b,11a-pentamethyl-8-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3bh,4h,9ah,11h-cyclopenta[a]phenanthrene-7,10-dione

C36H52O12 (676.3459)


   

(3s,4s,6r)-2,3-dihydroxy-2-methyl-6-[(1s,3r,6s,8r,9s,11s,12s,14s,15r,16r)-6,9,14-tris(acetyloxy)-7,7,12,16-tetramethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-15-yl]heptan-4-yl acetate

(3s,4s,6r)-2,3-dihydroxy-2-methyl-6-[(1s,3r,6s,8r,9s,11s,12s,14s,15r,16r)-6,9,14-tris(acetyloxy)-7,7,12,16-tetramethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-15-yl]heptan-4-yl acetate

C38H60O10 (676.4186)


   

(2s,3s,4r,5r,6s)-4,5-bis(acetyloxy)-6-{[(2r,3r,4s,5s,6r)-2-(hexadecyloxy)-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy}-2-methyloxan-3-yl acetate

(2s,3s,4r,5r,6s)-4,5-bis(acetyloxy)-6-{[(2r,3r,4s,5s,6r)-2-(hexadecyloxy)-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy}-2-methyloxan-3-yl acetate

C34H60O13 (676.4034)


   

(2s,3s,4r,5r)-6-{[(3s,4r,4ar,6ar,6bs,8as,12as,14ar,14br)-8a-carboxy-4-(hydroxymethyl)-4,6a,6b,11,11,14b-hexamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy}-3-ethoxy-4,5-dihydroxyoxane-2-carboxylic acid

(2s,3s,4r,5r)-6-{[(3s,4r,4ar,6ar,6bs,8as,12as,14ar,14br)-8a-carboxy-4-(hydroxymethyl)-4,6a,6b,11,11,14b-hexamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy}-3-ethoxy-4,5-dihydroxyoxane-2-carboxylic acid

C38H60O10 (676.4186)


   

methyl (1s,12r,14r,15e,18s)-12-[(1r,15s,17s,18s)-17-ethyl-7-methoxy-3,13-diazapentacyclo[13.3.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁸]nonadeca-2(10),4,6,8-tetraen-6-yl]-15-ethylidene-18-(hydroxymethyl)-17-methyl-10,17-diazatetracyclo[12.3.1.0³,¹¹.0⁴,⁹]octadeca-3(11),4,6,8-tetraene-18-carboxylate

methyl (1s,12r,14r,15e,18s)-12-[(1r,15s,17s,18s)-17-ethyl-7-methoxy-3,13-diazapentacyclo[13.3.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁸]nonadeca-2(10),4,6,8-tetraen-6-yl]-15-ethylidene-18-(hydroxymethyl)-17-methyl-10,17-diazatetracyclo[12.3.1.0³,¹¹.0⁴,⁹]octadeca-3(11),4,6,8-tetraene-18-carboxylate

C42H52N4O4 (676.3988)


   

(1r,3s,5s,6ar,7r,8r,9s,10s,10ar)-1,3-bis(acetyloxy)-7-[(2z)-3-ethenyl-4-hydroxybut-2-en-1-yl]-5,9-dihydroxy-7,8-dimethyl-1h,3h,5h,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-10-yl tetradecanoate

(1r,3s,5s,6ar,7r,8r,9s,10s,10ar)-1,3-bis(acetyloxy)-7-[(2z)-3-ethenyl-4-hydroxybut-2-en-1-yl]-5,9-dihydroxy-7,8-dimethyl-1h,3h,5h,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-10-yl tetradecanoate

C38H60O10 (676.4186)


   

(1r,3s,5r,6s,7s,8r,11s,12r,15s,29r,31r,33r,34s,35s)-6,7,34,35-tetrahydroxy-5,33-bis(hydroxymethyl)-12,29-dimethyl-2,4,9,14,30,32-hexaoxatetracyclo[29.4.0.0³,⁸.0¹¹,¹⁵]pentatriacontane-10,13-dione

(1r,3s,5r,6s,7s,8r,11s,12r,15s,29r,31r,33r,34s,35s)-6,7,34,35-tetrahydroxy-5,33-bis(hydroxymethyl)-12,29-dimethyl-2,4,9,14,30,32-hexaoxatetracyclo[29.4.0.0³,⁸.0¹¹,¹⁵]pentatriacontane-10,13-dione

C33H56O14 (676.367)


   

(2s,4r,5r,6r)-5-{[(2s,4s,5r,6r)-4,5-dihydroxy-4,6-dimethyloxan-2-yl]oxy}-4-hydroxy-6-methyloxan-2-yl (2s)-2-[(2s,3s,4r,5s,6r,8s,9s,10r,11r)-4,10-dihydroxy-8-[(2r,3r)-3-hydroxypentan-2-yl]-3,5,9,11-tetramethyl-1,7-dioxaspiro[5.5]undecan-2-yl]propanoate

(2s,4r,5r,6r)-5-{[(2s,4s,5r,6r)-4,5-dihydroxy-4,6-dimethyloxan-2-yl]oxy}-4-hydroxy-6-methyloxan-2-yl (2s)-2-[(2s,3s,4r,5s,6r,8s,9s,10r,11r)-4,10-dihydroxy-8-[(2r,3r)-3-hydroxypentan-2-yl]-3,5,9,11-tetramethyl-1,7-dioxaspiro[5.5]undecan-2-yl]propanoate

C34H60O13 (676.4034)


   

(1s,3r,3's,4r,5r,6s,7r,8s,10s,12s,16r,18s,21r)-7-hydroxy-3'-(2-hydroxypropan-2-yl)-4,6,12,17,17-pentamethyl-18-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}-9-oxaspiro[hexacyclo[11.9.0.0¹,²¹.0⁴,¹².0⁵,¹⁰.0¹⁶,²¹]docosane-8,2'-oxiran]-13-en-3-yl acetate

(1s,3r,3's,4r,5r,6s,7r,8s,10s,12s,16r,18s,21r)-7-hydroxy-3'-(2-hydroxypropan-2-yl)-4,6,12,17,17-pentamethyl-18-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}-9-oxaspiro[hexacyclo[11.9.0.0¹,²¹.0⁴,¹².0⁵,¹⁰.0¹⁶,²¹]docosane-8,2'-oxiran]-13-en-3-yl acetate

C37H56O11 (676.3822)


   

(1s,2s,4r,6s,9r,10r,11r,14r,15r)-9-hydroxy-6-(2-hydroxypropan-2-yl)-2,9,11,14,19,19-hexamethyl-17-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5-oxapentacyclo[12.8.0.0²,¹¹.0⁴,¹⁰.0¹⁵,²⁰]docosa-16,20-diene-8,13,18-trione

(1s,2s,4r,6s,9r,10r,11r,14r,15r)-9-hydroxy-6-(2-hydroxypropan-2-yl)-2,9,11,14,19,19-hexamethyl-17-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5-oxapentacyclo[12.8.0.0²,¹¹.0⁴,¹⁰.0¹⁵,²⁰]docosa-16,20-diene-8,13,18-trione

C36H52O12 (676.3459)


   

(2s,3as,6s,7as)-1-[(2r)-2-{[(2r)-1,2-dihydroxy-3-(4-hydroxyphenyl)propylidene]amino}-3-phenylpropanoyl]-6-hydroxy-n-{4-[n-(3-methylbut-2-en-1-yl)carbamimidamido]butyl}-octahydroindole-2-carboximidic acid

(2s,3as,6s,7as)-1-[(2r)-2-{[(2r)-1,2-dihydroxy-3-(4-hydroxyphenyl)propylidene]amino}-3-phenylpropanoyl]-6-hydroxy-n-{4-[n-(3-methylbut-2-en-1-yl)carbamimidamido]butyl}-octahydroindole-2-carboximidic acid

C37H52N6O6 (676.3948)


   

(1r,1'r,2r,3'r,4s,4'r,5s,5'r,6'r,10's,12's,13's,16'r,18's,21'r)-4-hydroxy-4',5,6',12',17',17'-hexamethyl-18'-[(3,4,5-trihydroxyoxan-2-yl)oxy]-3,6,9'-trioxaspiro[bicyclo[3.1.0]hexane-2,8'-hexacyclo[11.9.0.0¹,²¹.0⁴,¹².0⁵,¹⁰.0¹⁶,²¹]docosan]-3'-yl acetate

(1r,1'r,2r,3'r,4s,4'r,5s,5'r,6'r,10's,12's,13's,16'r,18's,21'r)-4-hydroxy-4',5,6',12',17',17'-hexamethyl-18'-[(3,4,5-trihydroxyoxan-2-yl)oxy]-3,6,9'-trioxaspiro[bicyclo[3.1.0]hexane-2,8'-hexacyclo[11.9.0.0¹,²¹.0⁴,¹².0⁵,¹⁰.0¹⁶,²¹]docosan]-3'-yl acetate

C37H56O11 (676.3822)


   

(3s,6s,9s,12s,15s,18s)-15-benzyl-8,11,17-trihydroxy-9-[(1r)-1-hydroxyethyl]-6-(hydroxymethyl)-3-isopropyl-13-methyl-12,18-bis(2-methylpropyl)-1,4-dioxa-7,10,13,16-tetraazacyclooctadeca-7,10,16-triene-2,5,14-trione

(3s,6s,9s,12s,15s,18s)-15-benzyl-8,11,17-trihydroxy-9-[(1r)-1-hydroxyethyl]-6-(hydroxymethyl)-3-isopropyl-13-methyl-12,18-bis(2-methylpropyl)-1,4-dioxa-7,10,13,16-tetraazacyclooctadeca-7,10,16-triene-2,5,14-trione

C34H52N4O10 (676.3683)


   

6,9-dimethyl (6r,9r)-10-[2-(3-ethyl-5,6-dihydro-2h-pyridin-1-yl)ethyl]-6-{3-[2-(3-ethyl-5,6-dihydro-2h-pyridin-1-yl)ethyl]-1h-indol-2-yl}-7h,8h,9h-pyrido[1,2-a]indole-6,9-dicarboxylate

6,9-dimethyl (6r,9r)-10-[2-(3-ethyl-5,6-dihydro-2h-pyridin-1-yl)ethyl]-6-{3-[2-(3-ethyl-5,6-dihydro-2h-pyridin-1-yl)ethyl]-1h-indol-2-yl}-7h,8h,9h-pyrido[1,2-a]indole-6,9-dicarboxylate

C42H52N4O4 (676.3988)


   

5-{[(1r,3ar,7r,8r,9as,11ar)-7-(acetyloxy)-1-[(2r,6r)-2-hydroxy-6-(2-hydroxypropan-2-yl)oxan-3-yl]-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-8-yl]oxy}-3-hydroxy-3-methyl-5-oxopentanoic acid

5-{[(1r,3ar,7r,8r,9as,11ar)-7-(acetyloxy)-1-[(2r,6r)-2-hydroxy-6-(2-hydroxypropan-2-yl)oxan-3-yl]-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-8-yl]oxy}-3-hydroxy-3-methyl-5-oxopentanoic acid

C38H60O10 (676.4186)


   

(1'r,2r,4'r,5s,5'r,10's,12's,13's,16'r,21'r)-4-hydroxy-4',5,6',12',17',17'-hexamethyl-18'-{[(2s)-3,4,5-trihydroxyoxan-2-yl]oxy}-3,6,9'-trioxaspiro[bicyclo[3.1.0]hexane-2,8'-hexacyclo[11.9.0.0¹,²¹.0⁴,¹².0⁵,¹⁰.0¹⁶,²¹]docosan]-3'-yl acetate

(1'r,2r,4'r,5s,5'r,10's,12's,13's,16'r,21'r)-4-hydroxy-4',5,6',12',17',17'-hexamethyl-18'-{[(2s)-3,4,5-trihydroxyoxan-2-yl]oxy}-3,6,9'-trioxaspiro[bicyclo[3.1.0]hexane-2,8'-hexacyclo[11.9.0.0¹,²¹.0⁴,¹².0⁵,¹⁰.0¹⁶,²¹]docosan]-3'-yl acetate

C37H56O11 (676.3822)


   

(1r,4s,5s,6s,8r,10r,11r,13s,17r,18r,19s,22s)-6-hydroxy-22-isopropyl-4,9,9,13,17-pentamethyl-10-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-20-oxahexacyclo[17.2.2.0¹,¹⁸.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tricos-14-en-11-yl acetate

(1r,4s,5s,6s,8r,10r,11r,13s,17r,18r,19s,22s)-6-hydroxy-22-isopropyl-4,9,9,13,17-pentamethyl-10-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-20-oxahexacyclo[17.2.2.0¹,¹⁸.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tricos-14-en-11-yl acetate

C38H60O10 (676.4186)


   

15-benzyl-8,11,17-trihydroxy-9-(1-hydroxyethyl)-6-(hydroxymethyl)-3-isopropyl-13-methyl-12,18-bis(2-methylpropyl)-1,4-dioxa-7,10,13,16-tetraazacyclooctadeca-7,10,16-triene-2,5,14-trione

15-benzyl-8,11,17-trihydroxy-9-(1-hydroxyethyl)-6-(hydroxymethyl)-3-isopropyl-13-methyl-12,18-bis(2-methylpropyl)-1,4-dioxa-7,10,13,16-tetraazacyclooctadeca-7,10,16-triene-2,5,14-trione

C34H52N4O10 (676.3683)


   

(2s,3r,4r,5r,6s)-2-{[(2s,3r,4r,5r,6s)-2-{[(2r,3r,4s,5r,6r)-3,5-dihydroxy-2-(hydroxymethyl)-6-{[(2e,6e,10e)-2,6,10-trimethyldodeca-2,6,10-trien-1-yl]oxy}oxan-4-yl]oxy}-4,5-dihydroxy-6-methyloxan-3-yl]oxy}-6-methyloxane-3,4,5-triol

(2s,3r,4r,5r,6s)-2-{[(2s,3r,4r,5r,6s)-2-{[(2r,3r,4s,5r,6r)-3,5-dihydroxy-2-(hydroxymethyl)-6-{[(2e,6e,10e)-2,6,10-trimethyldodeca-2,6,10-trien-1-yl]oxy}oxan-4-yl]oxy}-4,5-dihydroxy-6-methyloxan-3-yl]oxy}-6-methyloxane-3,4,5-triol

C33H56O14 (676.367)


   

(1r,2r,3as,3bs,9as,9br,11ar)-1-[(2r,4e)-2,6-dihydroxy-6-methyl-3-oxohept-4-en-2-yl]-2-hydroxy-3a,6,6,9b,11a-pentamethyl-8-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3bh,4h,9ah,11h-cyclopenta[a]phenanthrene-7,10-dione

(1r,2r,3as,3bs,9as,9br,11ar)-1-[(2r,4e)-2,6-dihydroxy-6-methyl-3-oxohept-4-en-2-yl]-2-hydroxy-3a,6,6,9b,11a-pentamethyl-8-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3bh,4h,9ah,11h-cyclopenta[a]phenanthrene-7,10-dione

C36H52O12 (676.3459)


   

(2r,3as,9br,11ar)-1-[(2r,4e)-2,6-dihydroxy-6-methyl-3-oxohept-4-en-2-yl]-2-hydroxy-3a,6,6,9b,11a-pentamethyl-8-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3bh,4h,9ah,11h-cyclopenta[a]phenanthrene-7,10-dione

(2r,3as,9br,11ar)-1-[(2r,4e)-2,6-dihydroxy-6-methyl-3-oxohept-4-en-2-yl]-2-hydroxy-3a,6,6,9b,11a-pentamethyl-8-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3bh,4h,9ah,11h-cyclopenta[a]phenanthrene-7,10-dione

C36H52O12 (676.3459)


   

5-amino-2-{[(2e,4e,6e,8e,10e,12e,14e,16e,18e,20e,22e,24e)-1-hydroxy-27-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]octacosa-2,4,6,8,10,12,14,16,18,20,22,24-dodecaen-1-ylidene]amino}pentanoic acid

5-amino-2-{[(2e,4e,6e,8e,10e,12e,14e,16e,18e,20e,22e,24e)-1-hydroxy-27-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]octacosa-2,4,6,8,10,12,14,16,18,20,22,24-dodecaen-1-ylidene]amino}pentanoic acid

C39H52N2O8 (676.3723)


   

(3r,4r,5r,6s)-4,5-dihydroxy-6-{[(1s,2s,5r,7s,10r,12s,15r,16r,17s,18r,21r,22r,24s)-21-hydroxy-22-methoxy-1,6,6,15,17,20,20-heptamethyl-19,23-dioxaheptacyclo[13.10.0.0²,¹².0⁵,¹⁰.0¹⁰,¹².0¹⁶,²⁴.0¹⁸,²²]pentacosan-7-yl]oxy}oxan-3-yl acetate

(3r,4r,5r,6s)-4,5-dihydroxy-6-{[(1s,2s,5r,7s,10r,12s,15r,16r,17s,18r,21r,22r,24s)-21-hydroxy-22-methoxy-1,6,6,15,17,20,20-heptamethyl-19,23-dioxaheptacyclo[13.10.0.0²,¹².0⁵,¹⁰.0¹⁰,¹².0¹⁶,²⁴.0¹⁸,²²]pentacosan-7-yl]oxy}oxan-3-yl acetate

C38H60O10 (676.4186)


   

(1s,1'r,2r,3'r,4s,4'r,5r,5'r,6'r,10's,12's,13's,16'r,18's,21'r)-4-hydroxy-4',5,6',12',17',17'-hexamethyl-18'-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}-3,6,9'-trioxaspiro[bicyclo[3.1.0]hexane-2,8'-hexacyclo[11.9.0.0¹,²¹.0⁴,¹².0⁵,¹⁰.0¹⁶,²¹]docosan]-3'-yl acetate

(1s,1'r,2r,3'r,4s,4'r,5r,5'r,6'r,10's,12's,13's,16'r,18's,21'r)-4-hydroxy-4',5,6',12',17',17'-hexamethyl-18'-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}-3,6,9'-trioxaspiro[bicyclo[3.1.0]hexane-2,8'-hexacyclo[11.9.0.0¹,²¹.0⁴,¹².0⁵,¹⁰.0¹⁶,²¹]docosan]-3'-yl acetate

C37H56O11 (676.3822)


   

4-hydroxy-4',5,6',12',17',17'-hexamethyl-18'-[(3,4,5-trihydroxyoxan-2-yl)oxy]-3,6,9'-trioxaspiro[bicyclo[3.1.0]hexane-2,8'-hexacyclo[11.9.0.0¹,²¹.0⁴,¹².0⁵,¹⁰.0¹⁶,²¹]docosan]-3'-yl acetate

4-hydroxy-4',5,6',12',17',17'-hexamethyl-18'-[(3,4,5-trihydroxyoxan-2-yl)oxy]-3,6,9'-trioxaspiro[bicyclo[3.1.0]hexane-2,8'-hexacyclo[11.9.0.0¹,²¹.0⁴,¹².0⁵,¹⁰.0¹⁶,²¹]docosan]-3'-yl acetate

C37H56O11 (676.3822)


   

(1r,4s,5s,6s,8r,10r,11r,13s,17r,18s,19s,22s)-6-hydroxy-22-isopropyl-4,9,9,13,17-pentamethyl-10-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-20-oxahexacyclo[17.2.2.0¹,¹⁸.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tricos-14-en-11-yl acetate

(1r,4s,5s,6s,8r,10r,11r,13s,17r,18s,19s,22s)-6-hydroxy-22-isopropyl-4,9,9,13,17-pentamethyl-10-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-20-oxahexacyclo[17.2.2.0¹,¹⁸.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tricos-14-en-11-yl acetate

C38H60O10 (676.4186)


   

11a-(hydroxymethyl)-3-isopropyl-3a,5a,5b,8,8-pentamethyl-1-oxo-9-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2h,3h,4h,5h,6h,7h,7ah,9h,10h,11h,11bh,12h,13h-cyclopenta[a]chrysen-10-yl acetate

11a-(hydroxymethyl)-3-isopropyl-3a,5a,5b,8,8-pentamethyl-1-oxo-9-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2h,3h,4h,5h,6h,7h,7ah,9h,10h,11h,11bh,12h,13h-cyclopenta[a]chrysen-10-yl acetate

C38H60O10 (676.4186)


   

(2s,3r)-2-[(14s)-14-{[(2r,3r,4r,5s,6r)-3,4-dihydroxy-6-(hydroxymethyl)-5-{[(2s,3r,4s,5s,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}pentadecyl]-4-methylidene-5-oxooxolane-3-carboxylic acid

(2s,3r)-2-[(14s)-14-{[(2r,3r,4r,5s,6r)-3,4-dihydroxy-6-(hydroxymethyl)-5-{[(2s,3r,4s,5s,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}pentadecyl]-4-methylidene-5-oxooxolane-3-carboxylic acid

C33H56O14 (676.367)


   

(2s,3s)-4-methylidene-5-oxo-2-[(14r)-14-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2r,3r,4s,5s,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}methyl)oxan-2-yl]oxy}pentadecyl]oxolane-3-carboxylic acid

(2s,3s)-4-methylidene-5-oxo-2-[(14r)-14-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2r,3r,4s,5s,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}methyl)oxan-2-yl]oxy}pentadecyl]oxolane-3-carboxylic acid

C33H56O14 (676.367)


   

(1s,2s,10r,11r,14r,15r,16s,17s,21s,23r)-17,21-dihydroxy-1,6,6,11,14,16,19,19-octamethyl-8-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-18,22-dioxahexacyclo[12.10.0.0²,¹¹.0⁵,¹⁰.0¹⁵,²³.0¹⁷,²¹]tetracosa-4,8-diene-7,12-dione

(1s,2s,10r,11r,14r,15r,16s,17s,21s,23r)-17,21-dihydroxy-1,6,6,11,14,16,19,19-octamethyl-8-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-18,22-dioxahexacyclo[12.10.0.0²,¹¹.0⁵,¹⁰.0¹⁵,²³.0¹⁷,²¹]tetracosa-4,8-diene-7,12-dione

C36H52O12 (676.3459)


   

1,3-bis(acetyloxy)-7-(3-ethenyl-4-hydroxybut-2-en-1-yl)-5,9-dihydroxy-7,8-dimethyl-1h,3h,5h,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-10-yl tetradecanoate

1,3-bis(acetyloxy)-7-(3-ethenyl-4-hydroxybut-2-en-1-yl)-5,9-dihydroxy-7,8-dimethyl-1h,3h,5h,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-10-yl tetradecanoate

C38H60O10 (676.4186)